14th CONGRESS OF THE EUROPEAN SOCIETY

Transcription

EUROPEAN SOCIETY
FOR SEXUAL MEDICINE
14th CONGRESS OF THE EUROPEAN
SOCIETY FOR SEXUAL MEDICINE
1 – 4 December 2011 > Milan Convention Centre, Italy
FINAL
PROGRAM
www.essm.org
hosted by: Sia - Società italiana di andrologia
14th Congress of the European Society for Sexual Medicine
Table of Content
Page
Welcome from the ESSM................................................ 3
ESSM History................................................................ 4
ESSM Committees......................................................... 5
ESSM Awards................................................................ 6
Acknowledgements......................................................... 8
MiCo Milano Congressi................................................... 8
General Information
MiCo Milano Congressi.........................................................9
Congress Registration Counter.............................................9
Registration Fees.................................................................9
Congress Language .............................................................9
Publication for Proceedings................................................10
CO CONGRESS ONLINE®...................................................10
Speakers Centre ...............................................................10
Internet Centre...................................................................10
ESSM Membership Issues..................................................10
Name Badges....................................................................10
Technical Exhibition...........................................................10
Poster Exhibition................................................................11
Electronic Posters on the ESSM Website.............................11
Coffee Breaks....................................................................11
Restaurants.......................................................................11
Cloakroom.........................................................................11
Bank.................................................................................11
Lost and Found..................................................................11
Mobile Phones...................................................................11
Program Changes..............................................................11
Insurance..........................................................................11
Currency............................................................................11
Electricity ..........................................................................11
Climate..............................................................................11
Congress and Exhibition Office
Office Hamburg
Hanser & Co GmbH
Zum Ehrenhain 34
22885 Barsbüttel | Germany
Phone:+49 – 40 – 670 88 20
Fax: +49 –40 – 670 32 83
Email: [email protected]
Scientific Secretariat
Andrea Salonia, MD
University Vita-Salute San Raffaele
Via Olgettina 60
20132 Milan | Italy
ESSM Secretariat
European Society for Sexual Medicine
ESSM Secretariat
Via Ripamonti 129
20141 Milan | Italy
Phone:+39 – 02 – 56601 625
Fax: +39 – 02 – 70048 577
CONGRESS VENUE
How to get to MiCo Milano Congressi............................. 12
Supporting Program...................................................... 13
A Personal Invitation from the ESSM President
Organ Concert...................................................................14
Structure of the Scientific Program................................ 15
Opening Ceremony....................................................... 17
Program Schedule........................................................ 18
Scientific Program
Thursday, 1 December 2011..............................................22
Friday, 2 December 2011..................................................27
Saturday, 3 December 2011..............................................34
Sunday, 4 December 2011................................................40
ABC Master Course (18 hours)...........................................42
Poster Presentations..................................................... 46
Guests@ESSM............................................................. 59
List of Exhibitors – Exhibition Plan................................ 60
List of Chairpersons and Presenters............................... 61
MiCo – Milano Congressi
Congress Entrance: Gate 14 (map on page 12)
Via Giovanni Gattamelata 5
20149 Milan | Italy
www.micmilano.it
Welcome from the ESSM
dear Congress Participants, dear Colleagues and friends,
hartmut Porst
andrea Salonia
Welcome to Milano, welcome to the 14th Congress of the European Society for Sexual Medicine.
it is a pleasure and an honour to have you as our guests and to share with you a very attractive
and exciting scientific program over the next 3 1/2 days. both the scientific and the educational
committee of ESSM have worked very hard for many months to finalise this ambitious congress
program. We are very sure that you will both enjoy this congress and see your scientific and clinical work in your daily practice benefit from the new scientific content. in this context i would
like to express my gratitude, from the bottom of my heart, to all colleagues in the various committees of ESSM who were directly involved and contributed actively to ensure this congress is a
complete success. My very special thanks are given to the chairs of the two committees very
deeply involved in preparing this congress, the Scientific and Educational Committees.
as you may have already recognized, this congress touches nearly all fields of Sexual Medicine,
extending from premature ejaculation to hot topics in hormonal replacement therapy of both
genders, from the state of the art management of priapism to the most recent update in hPV
management and vaccination, from breast cancer and its impact on women's sexuality to issues
in the elderly. i am very positive that everybody will find a special topic of interest during their stay.
The variety of the topics will be presented in many round-tables, state of the art lectures, podium
and poster sessions by renowned experts witnessing the broad spectrum of Sexual Medicine and
enabling each congress participant to put together a very individual congress program of interest.
for those who are attending the ESSM annual congress for the first time and would like to have
a grounding in Sexual Medicine, there is also a 3 day educational program, called the abC Master Courses in Sexual Medicine, that was put together for "beginners" to learn the basics in Sexual Medicine. but without any doubt this educational program is also an unique opportunity for
those who would like to refresh their knowledge in the special fields of Sexual Medicine. Take your
chance and make a selection of your choice for the future benefit of your patients.
The congress city Milan is a lively and dynamic city. built on the design and fashion industries,
it has long been considered the economic capital of italy. Today, Milan represents the largest
metropolitan area in italy and the sixth largest in Europe, with over six million inhabitants, making
it an important commercial hub and industrial centre within the EU and on the international
scene; as well as the largest italian centre for trade services, fashion, publishing and manufacturing. Milan is also home to the Stock Exchange and Europe's largest university and trade fair,
publishing and television centres. Milan also has magnificent palaces and ancient churches,
museums and art galleries, cinemas, theatres, shops and restaurants that make the city the
ideal place to enjoy the more unique and valuable masterpieces of italian art and to appreciate
its lively and Christmas atmosphere.
Last, but not least, i would like to express my gratitude to all of our sponsors and exhibitors,
especially to our major sponsor Eli Lilly and Company, who continue to be faithful and loyal to
ESSM guaranteeing that ESSM can continue with its ambitious scientific and educational work
in Sexual Medicine.
Enjoy this congress and spend a memorable time with us here in pre-Christmas Milano.
hartmut Porst
ESSM President
andrea Salonia
Local and Scientific Chairman
3
ESSM History
ESSM President
2001 Rome, Italy
Francesco Montorsi, Italy
Hartmut Porst, MD
Private Practise
Neuer Jungfernstieg, 62
20354 Hamburg | Germany
2002 Hamburg, Germany
Hartmut Porst, Germany
2003 Istanbul, Turkey
Emre Akkus, Turkey
Chairperson of the 14th ESSM Congress 2011
2004 London, UK
David Ralph, UK
Andrea Salonia, MD
University Vita-Salute San Raffaele
Via Olgettina 60
20132 Milan | Italy
2005 Copenhagen, Denmark
Petter Hedlund, Sweden
Annamaria Giraldi, Denmark
ESSM Presidents
2006 Vienna, Austria
Siegfried Meryn, Austria
1993 – 1997 Gorm Wagner, Denmark
2007 Lisbon, Portugal
Nuno Monteiro Pereira, Portugal
1997 – 1999 Inigo Saenz de Tejada, Spain
1999 – 2001 John Pryor, UK
2008 Brussels, Belgium
Joint Congress of ISSM/ESSM
Eric Wespes, Belgium (ISSM)
Claude Schulman, Belgium (ESSM)
2001 – 2004 Dimitrios Hatzichristou, Greece
2004 – 2007 Francesco Montorsi, Italy
2009 Lyon, France
Béatrice Cuzin, Lyon
François Giuliano, Paris
2007 – 2010 Ian Eardley, UK
2010 – 2013 Hartmut Porst, Germany
2010 Malaga, Spain
Antonio Martin Morales, Malaga
ESSM Congress, Venues and Chairmen
2011 Milan, Italy
Andrea Salonia, Italy
1995 Porto Carras, Greece
Dimitrios Hatzichristou, Greece
2012 Amsterdam, The Netherlands
Luca Incrocci, The Netherlands
2013Istanbul, Turkey
1997 Madrid, Spain
Inigo Saenz de Tejada, Spain
2000 Barcelona, Spain
Halim Hattat, Turkey
4
ESSM Committees
Clinical: Sexual Disorders
ChairFrancois Giuliano, France
MembersNicolae Calomfirescu, Romania
Juza Chen, Israel
Emmanuele Jannini, Italy
Marcel Waldinger, The Netherlands
Clinical: Surgery
ChairAtes Kadioglu, Turkey
Members
Luigi Cormio, Italy
Giulio Garaffa, UK
Sukbinder Minhas, Turkey
Women’s Sexual Health
Female Sexual Health
ChairRossella E. Nappi, Italy
Members
Johannes Bitzer, Switzerland
Selahittin Çayan, Turkey
Ellen Laan, The Netherlands
ESSM EXECUTIVE COMMITTEE
PresidentHartmut Porst, Germany
Past President Ian Eardley, UK
Secretary General Jens Sønksen, Denmark
Treasurer David Ralph, UK
Advisory Board
Representative Carlo Bettocchi, Italy
Members
Carla Costa, Portugal
Natalio Cruz, Spain
Béatrice Cuzin, France
Fabrizio Palumbo, Italy
Yacov Reisman, The Netherlands
Mustafa F. Usta, Turkey
The Couple
Psychosexual
Chair
Kevan Wylie, UK
Members
Loukas Athanasiadis, Greece
Stuart Brody, UK
Bente Traeen, Norway
Ex Office Members:
Editor of the
ESSM Newsletter Juan I. Martinez-Salamanca, Spain
Editors of the Arik Shechter, Israel
ESSM Website
Pedro Vendeira, Portugal
Basic Science
Chair
Mario Maggi, Italy
Members
Javier Angulo, Spain
Delphine Behr-Roussel, France
Giuseppe Cirino, Italy
Christian Gratzke, Germany
José La Fuente Carvalho, Portugal
ESSM SCIENTIFIC COMMITTEE
Chair Andrea Salonia, Italy
Sub-Committees
Men‘s Sexual Health
Clinical: ED
Chair
Kostantinos Hatzimouratidis, Greece
MembersIlan Gruenwald, Israel
Muammer Kendirci, Turkey
Nicola Mondaini, Italy
Thierry Roumeguère, Belgium
ESSM Educational Committee
MembersGiovanni Corona, Italy
Beatrice Cuzin, France
Natalio Cruz, Spain
Christina Damsted Petersen, Denmark
John Dean, UK
Ilan Gruenwald, Israel
Evie Kirana, Greece
René Kropman, The Netherlands
Yacov Reisman, The Netherlands
Clinical: Health Issues
Chair
Charalambos Vlachopoulos, Greece
MembersGiovanni Corona, Italy
Dirk Schultheiss, Germany
5
ESSM Committees
NATIONAL ORGANIZATION COMMITTEE
NATIONAL ORGANIZATION COMMITTEE
President Andrea Salonia
MembersGiorgio Franco
Ferdinando Fusco
Vincenzo Gentile
Bruno Giammusso
Paolo Gontero
Alessandra Graziottin
Nicola Mondaini
Giuseppe Morgia
Giovanni Muzzonigro
Rossella E. Nappi
Alessandro Palmieri
Roberto Ponchietti
Chiara Simonelli
Enrico Spera
Angela Vita
Alessandro Zucchi
Honorary Presidents Edoardo Austoni
Furio Pirozzi Farina
Patrizio Rigatti
Advisory Board
Mario Maggi
Vincenzo Mirone
Francesco Montorsi
Members
Emanuele Belgrano
Carlo Bettocchi
Giorgio Carmignani
Fulvio Colombo
Luigi Cormio
Giovanni Corona
Carlo Foresta
ESSM Awards
The ESSM Award of Excellence
This award is presented annually to a physician or scientist
(either in basic sciences or clinical practice) who has made
recent exceptional achievement in the field. Special consideration will be given to applications from less-experienced
researchers in Sexual Medicine.
THE ESSM Meeting Awards
The best presentations will be awarded with EUR 2.000 by
ESSM’s Award Committees.
1. Prize for the best presentation on FSD (preclinical)
2. Prize for the best presentation on FSD (clinical)
3. Prize for the best presentation on MSD (preclinical)
4. Prize for the best presentation on MSD (clinical)
5. Prize for the best surgical presentation
ESSM Award Winners
Best Presentation Awards
The ESSM Prestige Awards
1995 The Executive Committee of ESSM decided to establish
two awards to be presented during the annual meetings of
the society:
1997 Paul F. Engelhardt, Germany
Francois Giuliano, France
Suks Minhas, UK
The ESSM Career Award
This award will be presented to a senior scientist who has
made an outstanding contribution in the field. The Executive
and Scientific Committees will select the award winner. The
award winner will be presented during the Opening Ceremony.
2000 Apostolos Apostolidis, Greece
F. Mumtaz, UK
Christian Stief, Germany
2002 Annamaria Giraldi, Denmark
6
ESSM Awards
Career Awards
2003 Stefan Ückert, Germany
Ilan Gruenwald, Israel
Mustafa Usta, Turkey
Alberto Briganti, Italy
2002 John Pryor, UK
2003 Gorm Wagner, Denmark
2004 Byoung Ahn, Republic of Korea
Antonio Aversa, Italy
2004 Giles Brindley, UK
Ronald Virag, France
2005 Giovanni Corona, Italy
Elke Gizewski, Germany
Attila Kun, Hungary
Sava Perovic, Serbia
2005 Karl-Erik Andersson, Sweden
2006 Fotini Ferenidou, Greece
Giulio Garaffa, Italy
Wayne Hellstrom, USA
Linda Vignozzi, Italy
Guido van Wingen, The Netherlands
2009 Axel R. Fugl-Meyer, Sweden
2007 Inigo Saenz de Tejada, Spain
2008 Vaclav Michael, Czech Republic
2010Hans Hedlund, Norway
2011 Jacques Buvat, France
2007 Stephanie Ortigue, France
Dara Lazar, Austria
Ignacio Moncada, Spain
Jun-Kyu Suh, Republic of Korea
Tolga Akman, Turkey
Award of Excellence
2002 Petter Hedlund, Sweden
2003 Selim Cellek, UK
2008 David Ralph, UK
Judith Alder, Switzerland
Konstantinos Rokkas, Greece
K. Park, Republic of Korea
H. Gelez, France
2004 Stefan Ückert, Germany
2005 Javier Angulo, Spain
Ekkehard W. Hauck, Germany
2009Andrea Russo, Italy
Gert Holstege, The Netherlands
Yoram Vardi, Israel
Jas Kalsi and Giulio Garaffa, UK
2006 Andrea Salonia, Italy
2007 Antonio Aversa, Italy
2008 Delphine Behr-Roussel, France
2010 José La Fuente Carvalho, Portugal
Elisa Bandini, Italy
Fulvio Colombo, Italy
Jonathan Greggain, Canada
Andrea Burri, UK
2009 Giovanni Corona, Italy
2010 Tillmann Krüger, Germany
2011 Stephanie Ortigue, Switzerland
7
Acknowledgements
The organizers of the 14th Congress of the European Society for Sexual Medicine gratefully acknowledge the support of the
following companies (as per November 2011).
Major Sponsor
Sponsors
Eli Lilly
and Company
American Medical Systems B.V.
Direx GmbH
Itamar Medical
Kessel GmbH
Medispec Ltd.
Named S.p.A.
Pierre Fabre Médicament
Porgès-Coloplast
ProStrakan
Reflexonic
Timm Medical Technologies
Zephyr Surgical Implants
Main Sponsor
Bayer HealthCare
Pharmaceuticals
MiCo Milano Congressi – 1st floor
REG
IST
RAT
r's
ke
ea e
Sp ntr
Ce
Roo
Roo
mR
mB
Entrance
via escalators / stairs
from level 0 – ground floor
ION
R
Yel oom
low
Exh
lue
ed
Int
ern
e
tC
r
ent
e
Cof
P
Exh oster
ibit
ion
Sna
ck
Ba
r
8
fee
Are
a
ibit
ion
General Information
congress fees incl. ABC master course
MiCo Milano Congressi
Via Giovanni Gattamelata 5
20149 Milan (MI), Italy
www.micmilano.it
Entrance Gate for ESSM: Gate 14
Congress Registration Counter
All congress materials and documentation will be available at
the congress registration counter located in the entrance foyer on level 1 of the MiCo Milano Congress Centre. The congress staff will be pleased to help you with all enquiries regarding registration, congress material and congress program.
Please do not hesitate to contact the staff members if there
is anything they can do to make your stay more enjoyable.
Registration and Payment
after 1 Sept. 2011
ESSM Members,Physicians (MD)
EUR 600
Non-Members,Physicians (MD)
EUR 700
ESSM-Members with reduced
fees*:
Nurses, Residents in Training,
Scientists (PhD), Psychologists,
Therapists, Students
EUR 500
Non-Members with reduced fees*:
Nurses, Residents in Training,
Scientists (PhD), Psychologists,
Therapists, Students
EUR 600
Retired Delegates
EUR 100
Accompanying Persons
EUR 70
* A letter of the Chairman of the Department is necessary.
Opening Hours
Thursday, 1 December
08.00 h – 19.00 h
Friday, 2 December
07.00 h – 18.00 h
Saturday, 3 December
07.00 h – 18.00 h
Sunday, 4 December
07.00 h – 12.30 h
ABC Master Course fee (only)
During opening hours the congress counter can be reached at
Phone: +39 – 031 – 349 521
Registration and Payment
after 1 Sept. 2011
ESSM Members, Physicians (MD)
EUR 350
Non-Members, Physicians (MD)
EUR 400
Note: This fee is only valid for attending the ABC Master
Course and does not allow taking part in all the other congress
sessions.
Registration Fees
Congress Language
Registration fee for participants includes:
l Admission to all scientific sessions
l Admission to poster and technical exhibition
l Admission to the ESSM Opening Ceremony and
Welcome Reception on 1 December 2011
l Conference materials (delegate bag, final program,
abstract book, etc.)
l Coffee breaks from Friday, 2 December 2011 until
Sunday, 4 December 2011 ending with coffee
in the morning.
The congress language is English. Simultaneous translation
will not be provided.
Symposia in national languages organized by the national
affiliated societies SIA, ASESA / SPA, SFMS and AIHUS will
be offered on Thursday, 1 December from 10.00 h.
Registration fee for accompanying persons includes:
l Admission to the ESSM Opening Ceremony and
Welcome Reception on 1 December 2011
l Half Day City Sightseeing Tour of Milan on Friday,
2 December 2011 (pre-registration necessary)
9
General Information
Opening Hours
Thursday, 1 December
Friday, 2 December
Sunday, 4 December
Publication for Proceedings
The European Society for Sexual Medicine retains the right
to publish all material presented at the congress in an
ESSM publication.
08.00 h – 19.00 h
07.00 h – 18.00 h
07.00 h – 18.00 h
07.00 h – 12.30 h
Operated by Estensis GmbH –
the Conference Company
CO CONGRESS ONLINE®
Participants can benefit from the web based ESSM Congress
Information System CO CONGRESS ONLINE® at
www.essm-congress.org
Internet Centre
Several Internet terminals are available to all delegates at the
exhibition area in the Exhibition Hall B of the MiCo. The Internet centre is accessible according to the opening hours of
the exhibition.
By courtesy of the major sponsor
CO CONGRESS ONLINE® offers an extensive congress service
and provides you with information on:
l Updated scientific program
l Program by day
l Program by formats with accepted abstracts of chairpersons
and speakers
l Program search
l List of participants (who is who)
l List of exhibitors and sponsors
l Social Events
l General congress information
l Supporting program
l City of Milan
l Hotel accommodation
l Travel to Milan
l News
l Private mailbox
ESSM Membership Issues
For ESSM membership issues and any other ESSM business,
please contact our ESSM booth which is situated in the exhibition area in Hall B opposite the session halls.
Name Badges
All participants are kindly requested to wear their name badge
at all times during the congress. The colours of the name
badge have the following significance:
Congress Delegate: blue
Accompanying person: orange
Press: yellow
Exhibitor: green
Staff: red
ABC Master Course: pink
Speakers Centre
The speakers centre is located on level 1 of the congress
centre. Speakers are asked to hand in their CD ROM or USB
stick, containing the PowerPoint presentation (IBM format or
compatible, no multisession) preferably one day before their
presentation but at the latest 90 minutes prior to the presentation. The presentation will be transferred to the central congress server and will be available afterwards on a special
congress notebook in the hall of the presentation. Due to time
and technical reasons we kindly ask the speakers not to use
their own notebook. Several PC working stations are provided
in the speakers centre where speakers can also work on their
PC charts in a quiet area. Technical staff will be glad to assist.
Technical Exhibition
The technical exhibition will be organized in the Exhibition
Hall B on level 1 of the MiCo Congress Centre next to the
main session rooms. Coffee bars will be located in the technical exhibition.
Opening Hours
Friday, 2 December
Sunday, 4 December
10
09.00 h – 17.30 h
09.00 h – 17.30 h
09.00 h – 12.30 h
General Information
Poster Exhibition
Bank
Posters will be sited in Exhibition Hall B, where the technical
exhibition will take place. Special highlighted posters will be
displayed in a dedicated area of the exhibition.
An ATM machine can be found inside the MiCo in the foyer
of level 1 close to main escalator. Another one ist outside
between Gate 16 and 17.
Highlighted poster tours will take place during the coffee breaks
on Friday and Saturday. Each poster tour includes eight poster presentations chaired by a senior scientist. For further
information please see from page 28 of the scientific program.
Opening Hours
Friday, 2 December
Sunday, 4 December
Lost And Found
A lost and found service is available at the registration counter.
Mobile Phones
09.00 h – 17.30 h
09.00 h – 17.30 h
09.00 h – 12.30 h
Delegates are kindly requested to keep their mobile phones
turned off while attending the scientific sessions in the meeting rooms.
Electronic Posters on The ESSM Website
Program Changes
All poster presentations will be displayed on the ESSM website after the congress. All poster authors who have not yet
submitted their poster are kindly asked to do so electronically
either on CD ROM or on USB stick at the speakers centre on
the ground level of the congress centre.
The organizers cannot assume liability for any changes in the
congress program due to external or unforeseen circumstances.
Insurance
Coffee Breaks
The congress fee does not include insurance. All participants
are advised to arrange for their own insurance. Health and
accident insurance is recommended and has to be purchased
in your country of origin. The organizers will not be responsible for a loss or damage of personal belongings.
Coffee and tea will be served during the morning and afternoon
coffee breaks from Friday, 2 December to Sunday, 4 December 2011 free of charge to all participants wearing congress
name badges. On Sunday, the coffee bar will be open during
the morning from 09.00 – 12.00 h.
Currency
Restaurants
The official Italian currency is EUR. Credit cards are fitly
accepted.
A snack bar is provided in the Exhibition Hall B, where you
can buy food, such as snacks and dishes.
Electricity
Cloakroom
Voltage is 220V AC, 50 Hz. Plugs have two or three round
pins. Foreign voltage could require an adapter.
A cloakroom of your own expenses is available close to the
Congress Counter. You can also store your luggage here.
Price per day and coat: EUR 3.
Climate
The climate in Milan is moderate in winter with possible precipitation. The average temperature during the day in December is 8° Celsius.
11
how to get to MiCo Congressi
switch to the red Line 1 (rho fiera Milano direction) and
get off at “amendola” – 1 km from MiCo Congressi / fiera
Milano City.
PUbLiC TranSPorT
Milan has a comprehensive transport network run by azienda Trasporti Milanesi (aTM). Services operate daily from
6.00 to 24.00 hrs. Tickets can be bought from newsagents,
tobacconists, most coffee bars and automatic selling machine at major metro and bus stops. no tickets available on
the buses. The metro has three lines: red (MM1), green
(MM2), yellow (MM3). The lines converge at duomo, Stazione Centrale, Loreto and Cadorna.
Yellow Line 3: get off at “duomo”, switch to the red Line 1
(rho fiera Milano direction) and get off at “amendola” –
1 km from MiCo Congressi / fiera Milano City or stop at “Cadorna”, leave the Metro and go up to the railway station above:
take the first train and get off at “domodossola” – just 400 m
from MiCo Congressi / fiera Milano City.
hoW To rEaCh ThE CongrESS VEnUE bY METro
TaxiS
Red Line 1: get off at “amendola” – 1 km from MiC Centre
– or stop at “Cadorna”, leave the Metro and go up to the railway station above: take the first train and get off at “domodossola” – just 400 m from MiCo Congressi / fiera Milano City.
Taxis are white and can be hailed on the streets. it is better
to hire them at taxi ranks. Telephone booking is possible
and run by cooperatives at the following numbers: (+39) 02
6767, (+39) 02 4040, (+39) 02 8585, (+39) 02 6969.
Green Line 2: get off at “Cadorna”, leave the Metro and go
up to the railway station above: take the first train and get
off at “domodossola” – just 400 m from MiC Centre, or
aCCESS To MiCo CongrESS / fiEra MiLano
Congress Entrance:
l Gate 14
from station:
l LOTTO
Fiera Milano City
from station:
l Amendola
12
Supporting Program
MiLan WaLKing ToUr
Friday, 2 December 2011
09.15 – 12.30 h
Meeting point:
Sforza Castle ǀ Piazza Castello 3, close to the fountain
Metro Station: Cairoli (MM1 – red line)
Meeting with an English speaking guide and departure from
Sforza Castle.
Join a walking tour in the heart of Milan with departure from
Sforza Castle. a visit to the yards is followed by a visit to one
of the castle museums, Museum of ancient art with the
Pietà rondanini by Michelangelo.
afterwards a gentle walk through Via dante with arrival at the
duomo square will follow where you will visit the gothic Cathedral with the famous Madonnina, the symbol of Milan.
next you are guided to the galleria Vittorio Emanuele ii, this
stands for a witness of the iron architecture in Milan and of
the La Scala opera house, which is recognized as one of the
leading opera and ballet theatres of the world. The tour will
end at La Scala square.
Price per person:
EUr 42
© fiera Milano Congressi
The price includes:
l Ticket for La Scala Theater, Pietà rondanini
l Explanation via headset during the visit of Milan duomo
for registered accompanying persons this tour is complimentary and necessary to reserve in advance. Please contact the registration counter.
Castello Sforzesco
13
a Personal invitation from the ESSM President
friday, 2 december 2011, 20.00 – 21.00 h
dear Colleagues and friends,
it is a great pleasure and honour for me to invite you on friday, 2 december 2011, 20.00 to 21.00 h to a special
pre-Christmas organ concert at the basilica of Sant' ambrogio, one of the most ancient churches in Milan.
i would be very pleased if you have the opportunity to join us, the ESSM officers, and spend with us some relaxed
and inspiring time listening to festive pieces in a distinguished location here in the historical center of Milan.
With warm regards
hartmut Porst
ESSM President
Music pieces
, Suite in Fa maggiore, g.f.haendel (halle 1685 – Londra 1759)
, Concerto in Re minore, J.S.bach (Eisenach 1685 – Lipsia 1750)
, Nun Komm der Heiden Heiland (bWV 659 Corale Schubler)
, Wachet auf ruft uns die Stimme (bWV 645 Corale Schubler)
, Suite du Premiere, Ton L.n. Clerambault (Paris 1714 – Paris 1749)
, Improviso su, The First Nowell (oxford 1883 – London 1947)
, Cantique de Noel (Paris 1803 – Paris1856)
, Redemption M.E. bossi (Salò 1861 – atlantic ocean 1925)
sant' ambrogio Church
one of the most ancient churches in Milan,
it was built by St. ambrose in 379 – 386
How to get to the Sant' Ambrogio Church
Piazza Sant' ambrogio 15
Take the green line 2 (MM2) to
l metrostation Sant' ambrogio, city centre
14
Structure of the Scientific Program
Structure of the Abstract Book
The scientific program is structured according to days. Per
day it is structured by time and room. All presenters are
listed by name and the title of their presentation.
The abstract book is structured by session format. The listing
starts with the podium session followed by the highlighted
poster sessions. Hereafter the poster presentations are listed
according to topics.
Master Lectures
dealing with surgery, hormonal replacement therapies in women and men, STDs and gender identity disorders. Moreover,
as a clear cut innovation, ESSM has added a new 3-day Master Course on the ABC of Sexual Medicine to the European
Continuing Medical Education opportunity for specialists in
the field. The ABC Master Course – true pride of ESSM – will
incorporate endocrinological, urological, surgical, gynaecological, psychological and other diagnostically and therapeutically aspects in Sexual Medicine in order to cater for both
practitioners and trainees.
Each 30 minutes lecture will be given by a distinguished and
renowned expert and will be devoted to a specific topic of
major interest.
Round Tables
These sessions will usually last 60 to 90 minutes. They will
focus on a particular topic and present the very latest data
related to it. The round table will include a maximum of four
papers and time for discussion.
Debate
The ISSM ESSM debate lasts for 60 minutes and is designed
to cover controversial issues of a particular topic. The debate
starts with a 20 minutes lecture followed by a discussion of
respective opponents on the arguments proposed. Comments,
arguments, and questions from the floor are welcome during
the discussion.
Live Surgery
Live surgery was the top request for future ESSM congresses
in the delegate feedback. Having this in mind, ESSM has thus
included a 4-hours Live Surgery session across the main program of the 14th annual congress. The session is scheduled
for December 4th, Sunday morning. In order to make the session more useful and exciting, the ESSM decided to dedicate
it to 4 relatively young surgeons with a good profile in the field
of andrological surgery, with top international experts at their
side, demonstrating cutting edge techniques and new tricks
in a lively format. The use of multiple cases and experienced
chairpersons will ensure interactive learning without unnecessary gaps. The surgery will be broadcasted live from the Department of Urology of the San Raffaele Hospital in Milan.
Educational Courses
These 90 minutes sessions present a detailed account of a
chosen topic. Courses are designed to provide learning experiences that actively involve participants and will include
an opportunity for informal exchange with the faculty. Attendees will be given the possibility to interact actively via a voting
system with the faculty of the session.
ABC Master Course
Video Surgery Course
The ESSM Scientific Committee along with the Educational
Committee continues to enthusiastically work with the specific aim to eventually improve the cultural and educational
proposal during the various sessions of the annual congress.
In this context, the 14th ESSM annual congress may propose
up to 10 Instructional Courses with the highest level of scientific, rigor and European top experts in the different fields,
The Video surgery Course will last 90 minutes, each video
has an average duration of 10 minutes. A panel of selected
experts will present surgical videos showing different techniques and approaches and will discuss the details with
the participants.
15
Podium Sessions
CME Accreditation
Podium sessions will present the best abstracts accepted for
the Congress by the Scientific Committee and will focus on
their specific topics presenting the very latest findings in this
field. The sessions will last 30 to 90 minutes. Presentations
are limited to 3 minutes followed by 2 minutes of discussion
The 14th Congress of the European Society for Sexual Medicine is accredited by the European Accreditation Council for
Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is
an institution of the European Union of Medical Specialists
(UEMS), www.uems.net.
Highlighted Poster Tours
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Full
congress days count for 6 credits, half congress days for
3 credits. Thus a maximum of 15 European CME credits can
be obtained.
Authors were invited to submit abstracts on their latest research findings or important ongoing research. The highlighted poster tours were selected by the Scientific Committee
based on a review of all abstract submissions. The most interesting posters are grouped by topic and presented in a
30-minute moderated tour. Each tour will consist of a maximum of 8 posters in the same general field and will take place
during the coffee breaks on Friday and Saturday.
EACCME credits are recognized by the American Medical
Association towards the Physician’s Recognition Award (PRA).
To convert AECCME credit to AMA PRA category 1 credit, the
AMA may be contacted.
In order to obtain CME credits, we kindly ask the delegates
to complete the evaluation form enclosed in the congress
bag. Please hand in your form at the ESSM booth in the exhibition hall, the certificate (UEMS) will be distributed there.
Symposia in National Language
The affiliated national societies of the ESSM have been invited
to organize symposia in their national language during the
first congress day of the annual ESSM congress.
Symposia organized by the Industry
Symposia organized by the Industry in consultation with the
Scientific Committee will be presented Thursday, 1 December
2011 prior to the Opening, Friday, 2 December 2011 during
lunch time and in the afternoon as well as Saturday, 3 December again during lunch time.
16
Opening Ceremony
Thursday, 1 December 2011, 18.30 – 19.30 h
The Martinitt
The “Martinitt" orphanage in Milan has been a part of the city's history since the Renaissance. Its foundation dates from the height
of the Renaissance. According to recent studies, it seems that the orphanage was founded in the year 1532, when Duke Francesco
Sforza II summoned the Venetian nobleman Gerolamo Emiliani, who had already founded another orphanage in the North of
Italy. Few years after the foundation, the very same men moved the orphanage to a bigger house. The church of San Martino was
built near the new house, and the children living at the orphanage took the name of Martinitt, based on the nearby church.
Since the beginning, at the orphanage, great attention was given to education: the Martinitt learned to read and write, they attended music lessons and sang in the choir. Orphans were also taught the fundamentals of these crafts that allowed children, after
leaving the institution, to support themselves with the fruits of their labour.
During the sixteenth and seventeenth centuries the institution had a great reputation and the growing number of orphans was
matched with an increase in donations, bequests and inheritance devolved to the institution from the noble and wealthy of the city.
During the nineteenth century, new courses of study were introduced and the orphans began to attend apprenticeships at external workshops. At that time the glorious “Banda dei Martinitt” was founded too. This band is still known and active today. If at
the beginning of its history the band was composed of boys living at the institute, the band is now composed of talented young
professional musicians with national and international curricula.
The “Banda dei Martinitt” performs during main events taking place in Milan (like New Year's concert and the parade for the
celebration of the liberation on April, 25th), is part of various prestigious national venues (including television programs and
feature films) and international events (unforgotten is still the band's 1994 meeting in Monte Carlo). Today, the huge building
complex of Martinitt is ready to become the prestigious seat of a university campus.
18.30 h l l Welcome Speech by the ESSM President Hartmut Porst, Germany
ESSM Grants and Award Ceremony
Introduction on the ESSM Website www.essm.org
Arik Shechter, Isreal and Pedro Vendeira, Portugal
Examination in Sexual Medicine, Ian Eardley, United Kingdom
Welcome Speech by the Local and Scientific Chair Andrea Salonia, Italy
Banda dei Martinett
19.30 h l l Welcome Reception in the foyers
17
Program Schedule
Thursday, 1 December 2011
Room
Red Room
Time
Blue Room 1
Blue Room 2
Yellow Room
09.00
Foyer
Registration
08.00 – 19.00 h
10.00
ABC Master Course
Part I (page 42 – 44)
11.00
SN-02
ASESA
12.00
13.00
SN-01
SIA / Società Italiana di
Andrologia
Symposium in
national language
(Italian)
SN-03
SFMS
Symposium in
national
language
(Spanish)
Symposium in
national
language
(French)
ML-00
ESSM Grant Lecture
14.00
15.00
SN-04
AIHUS
Symposium in
national language
(French)
VC-01
PS-01
Video Surgery
Course
RT-1
Male sexual
health
PDE5is for ed:
What fits best
with a couples’
sexual ecology?
16.00
ABC Master Course
Part II (page 42 – 44)
PS-02
Basic science –
preclinical
research
SA-01
17.00
18.00
19.00
Patients‘ perspective on coping
with severe ED: Satisfaction with a
permanent solution (AMS)
D-01
Adverse events associated with
testosterone therapy
Opening Ceremony
Get Together in the Foyers
20.30
Abbreviations
SN – Symposia in national language
RT –Round Table
M
ML – Master Lecture
– Master Course
SA – Satellite Symposia
EC–Course
D –Debate
PS – Podium Session
VC – Video Surgery Course
HP –Highlighted Poster Session
18
BSSM
Scientific
Meeeting
White Room, Level 2
Program Schedule
Room
Red Room
Time
Blue Room
Yellow Room
Foyer / Hall B
07.00
Foyer
08.00
EC-01
Andrological emergencies
(priapism, closed penile fracture,
severe genital trauma)
EC-02
EC-03
Contemporary clinical management Contraception and HRT for women
of erectile dysfunction: How to
in contemporary clinical practice
practically approach men with
cardiological comorbidities
09.00
10.00
11.00
12.00
RT-02
RT-03
ML-01 Epidemiology and sexual
medicine: New challenges and ...
PS-01B
Surgery in motion: Common
complex problems in clinical
practice
RT-04
14.00
Part III (page 42 – 44)
Sexual health and pelvic disease
15.00
Coffee Break / Highlighted Posters 03 / 04
16.00
17.00
HP-02
18.00
Psychosexual issues
Lunch Break
Pasta snack served from 13.00 h
RT-07
Protection of intellectual property
Groundbreaking treatment for
Erectile Dysfunction using EDSWT
(Medispec)
RT-08
RT-09
EC-04
EC-05
Gender reassignment surgery
ABC Master Course
SA-04
PS-04
Men’s health – understanding the
role of testosterone
Basic science
Endometriosis and female sexuality
PS-03
Women's sexual health
11.00 – 11.30 h
Highlighted Posters:
HP-01
RT-05
Why What When: Facets of human
sexuality – from evolutionary to treatment success (Eli Lilly and Company)
RT-06
Technical and
Poster Exhibition
09.00 – 17.30 h
ABC Master Course
Male sexual health
SA-02 / Luncheon Satellite
13.00
Hall B
Sexuality in patients with physical
and psychiatric disabilities
Coffee Break / Highlighted Posters 01 /02
hpv awareness in men
Registration
07.00 – 18.00 h
Part IV (page 42 – 44)
15.00 – 15.30 h
HP-03
Women's sexual
health
Surgery
HP-04
Surgery
Contraception versus sexuality:
Who is the winner?
Gynaecological disorders in sexual
medicine
Italians@ESSM2011(Italian)
Testosterone = tumore della
prostata!
19.00
20.00
ESSM Organ Concert at Saint Ambrogio Church
19
Program Schedule
Saturday, 3 December 2011
Room
Red Room
Time
Blue Room
Yellow Room
Foyer / Hall B
07.00
Foyer
08.00
EC-07
EC-06
What the sexual physician needs to The role of penile prosthesis in
know about sexually transmitted
contemporary sexual medicine
infection
practice
EC-08
Contemporary clinical management
of male testosterone deficiency
syndrome – a practical approach in
the everyday clinical practice
09.00
10.00
11.00
RT-10
RT-11
ML-03
ML-04
Sexual activity after a myocardial
infarction: a sweet hereafter?
ISSM lecture
Sexually transmitted diseases:
Stay vigilant!
Men's changing sexuality, identity
and behaviour (Bayer HealthCare
Pharmaceuticals)
14.00
RT-14
Sexuality in the elderly
15.00
Part V (page 42 – 44)
11.00 – 11.30 h
RT-13
Preclinical research in 2011 –
is pipeline empty?
HP-05
Male sexual health
Lunch Break
The “Sandra Leiblum” lecture
RT-16
Common sexual problems that are
still difficult to treat
Genital dermatology
18.00
19.00
Men's sexual health
ABC Master Course
RT-15
Onco-sexual medicine – only a
neologism or a new concept?
Part VI (page 42 – 44)
15.00 – 15.30 h
ML-06
HP-07
The importance of a “smile” in sex
Surgical potpourri
RT-17
HP-08
Cultural differences may significantly impact treatment offered
Sexual potpourri
17.00
EC-09
HP-06
Pasta snack served from 13.00 h
ML-05
16.00
Technical and
Poster Exhibition
09.00 – 17.30 h
ABC Master Course
History lecture@ESSM
SA-03 / Luncheon Satellite
13.00
Hall B
Practical management of surgical
complications
RT-12
12.00
Registration
07.00 – 18.00 h
EC-10
Contemporary clinical management
of women's sexual problems: A
practical approach in the everyday
clinical practice
ESSM Annual
Business Meeting
(for members only)
20.00
20
Italians@ESSM2011(Italian)
Sesso, educazione, comuni-cazione e web
Program Schedule
Sunday, 4 december 2011
Room
Red Room
Time
Blue Room
07.00
Foyer / Hall B
Foyer
registration
07.00 – 13.00 h
08.00
Hall B
Technical and
Poster Exhibition
09.00 – 12.30 h
09.00
live surgery session
10.00
is andrological surgery heritage of young surgeons?
transmitted from
University hospital San raffaele
Rt-18
drugs are dangerous for women’s sexual health!
esHa session
how does the Ed couple deal with fake medicines:
a clinical perspective
11.00
Rt-19
breast cancer: The quality of life and effect on
sexuality of young women
12.00
13.00
Closing Ceremony
21
Coffee is served
in the exhibition from
09.00 to 12.00 h
Scientific Program
SIA-01-01
Symposium
11.00 – 14.00 h
ASESA-01
Red Room
Symposium
10.00 – 14.00 h
Blue Room 1
ASESA Symposium – Spanish language
Chairman of the Day: Furio Pirozzi Farina, Italy
Bienvenida. Presentación
Ana Segura / Rafael Prieto
11.00 – 12.30 h
SIA Smyposium: La chirugia andrologica é in mano ai
giovani? – Italian language
Chairpersons:Alessandro Palmieri, Italy
10.15 – 11.15 h
Cirugía de pene
Moderador: Fernando Meijide
La chirurgia protesica
Federico Dehò, Italy
Cirugía uretral y sus repercusiones andrológicas
Venancio Chantada
La chirurgia cosmetica e funzionale dei genitali esterni
Cirugía reconstructiva del pene
Natalio Cruz
La chirurgia di genere
Giovanni Liguori, Italy
Enfermedad de La Peyronie: Del siglo XVIII al XXI
Joaquim Sarquella
Quali sono i reali desiderata del/della partner?
Alessandra Graziottin, Italy
11.30 – 12.30 h
Disfuncion eréctil
Moderador: Pedro Vendeira / Rafael Prieto
12.30 – 13.00 h
La vita viagra (uomini, pillole, sesso e relazioni)
Chairperson: Enrico Spera, Italy
Lecturer:
Mariangela Mianiti, Italy
Tipos de respuesta sexual y adicción a sustancias
(Estudio TIRESIAS)
Francisco Javier del Río
13.00 – 14.00 h
Tratamiento de la disfunción eréctil con ondas de choque
Ignacio Moncada
La sessualità femminile: riflessioni e interventi
Chairpersons:Adele Fabrizi, Italy
Chiara Simonelli, Italy
Ventajas e inconvenientes del tratamiento con iPDE5 a
demanda / diario
Mesa interactiva. Debate entre los asistentes
Arousal genitale e ultrastruttura clitoridea
Salvatore Caruso, Italy
12.30 – 13.30 h
Testosterona y función sexual
Moderador: Martín Santisteban
Agire sul corpo per cambiare la mente: la terapia evoluta
del vaginismo
Roberto Bernorio, Italy
La ciencia del deseo
Francisco Cabello
Sessualità femminile e obesità
Roberta Rossi, Italy
Implicación de la Testosterona en el síndrome metabólico
y función Sexual
Manuel Mas
Erección y testosterona: abordaje en la consulta de Andrología
Eduardo García-Cruz
13.30 – 13.40 h
Recomendaciones y sugerencia para publicar en la RIA
Pedro Gutiérrez
13.40 – 13.50 h
Cierre de la sesión. Despedida
Ana Segura / Rafael Prieto
22
Scientific Program
SFMS-01
Symposium
10.00 – 14.00 h
ML-00
Blue Room 2
Master Lecture
12.20 – 13.30 h
Yellow Room
SFMS Symposium – French language
Société Francophone de Médecine Sexuelle
ESSM Grant Lecture
Chairperson: Carla Costa, Portugal
10.00 h
Ouverture / Introduction
Jacques Buvat, Lille
ML-00-01
10.05 h
Symposium
Dopamine modulates reward system activity
during subconscious processing of sexual
stimuli
Stephanie Both, The Netherlands
Du point G à l'éjaculation féminine: pleins
feux sur le continent noir
Modération: Hélène Dugrè, Montréal,
Gilbert Bou Jaoudé, Lille
ML-00-02
Ejaculation féminine ou incontinence coïtale?
Béatrice Cuzin, Lyon
Neurobiological mechanisms of lifelong
retarded ejaculation: a translational approach using human neuroimaging and
comparative animal research
Janniko Georgiadis, The Netherlands
ML-00-04
Y-a-t'il vraiment des différences entre orgasmes clitoridien ou vaginal?
Stuart Brody, Paisley, Ecosse
L'orgasme aurait-il une origine urétrale?
Patrice Cudicio, Rennes
Intracavernosal bone marrow-derived mesenchymal stem cell therapy combined with
tadalafil administration for the recovery of
erectile function after cavernous nerve injury
Juan Ignacio Martínez-Salamanca, Spain
L'orgasme n'est-il pas avant tout cérébral?
Marie Hélène Colson, Marseille
14.00 – 16.00 h
12.05 h
Pause plateau-repas
AIHUS Symposium – French language
12.20 h
Mise au point d'actualité
Modérateur:Marc Galiano, Paris,
Mohand Issad, Alger
Les violences sexuelles, du constat aux actions /Sexual
violences, from report to actions
Dix ans de traitement par la testostérone
après cancer de la prostate supposé guéri:
la fin d’une contrindication?
Luiz Otavio Torres, Belo Horizonte, Brésil
12.45 h
Débats
Modérateurs: Dr Pierre Alarie, Montréal,
Dany Jawhari, Dijon
Dysfonction érectile avec testostérone basse:
quel traitement en première intention?
AIHUS-01
Testostérone
Jacques Buvat, Lille
ou IPDE5?
Hélène Dugrè, Montréal
13.15 h Ejaculation prématurée: Il est temps de
reconnaître l’inefficacité des traitements
sexologiques sans traitement pharmacologique associé
Pour: Pierre Assalian, Montréal
Contre: François de Carufel, Bruxelles
13.50 h Conclusions et clôture de la session
23
Symposium
Red Room
14.00 h
Introduction
Pierre Foldès, Mireille Bonierbale, Antoine
Faix
14.05 h
Quel impact en santé publique? / What impact in Public Health?
Nicole Arnaud-Beauchamps, Béatrice Cuzin
14.25 h
Les violences sexuelles conjugales / Marital
sexual abuses
Pierre Blachère
14.45 h
Les mutilations sexuelles féminines / Female genital mutilation
Pierre Foldès
15.05 h
Les femmes aussi: les abus sexuels commis par les femmes / Women also sexual
abuse committed by women: frequence,
characteristics
Marie-Hélène Colson
Scientific Program
15.25 h
Les hommes également: les victimes masculines / Men as well: male victims
Audrey Gorin
15.45 h
Discussion
15.55 h
Conclusion
Mireille Bonierbale et Pierre Foldès
V-01
PS-01-002
PS-01-003 Testosterone in hypertensive men with
erectile dysfunction: A secret player?
Nikolaos Ioakeimidis, Greece
C. Vlachopoulos, K. Rokkas, D. TerentesPrintzios, A. Samentzas, T. Askitis, K. Aznaouridis, C. Stefanadis
14.00 – 15.30 h
Blue Room 1
Chairpersons:David Ralph, United Kingdom
Ates Kadioglu, Turkey
V-01-001
Management of genital lymphoedema
Ahmed Shamsodini, Qatar
V-01-002
Penile implant insertion in longstanding
priapism
Christopher Nim, United Kingdom
V-01-003
Apical tunical repair in implant surgery
Omid Reza Sedigh, Italy
V-01-004
One stage penis reconstruction after failed
hypospadras repair
Rados Djinovic, Serbia
V-01-005
Penile reconstruction for BXO of the penis
Suks Minhas, United Kingdom
V-01-006
Salvage of inflatable penile prosthesis due
to aneurysmatic dilatation
Matteo Marzotto Caotorta, Italy
V-01-007
Surgical treatment of low flow priapism.
Which technique and why?
V-01-008
Correction of ventral penile curvature by geometric principles
Salvatore Sansalone, Italy
PS-01
Podium Session
14.00 – 15.30 h
PS-01-004
Long acting testosterone undecanoate improved ageing male symptom scores but
not depression versus placebo in a hypogonadal population with type 2 diabetes
Geoffrey Hackett, United Kingdom
PS-01-005
Body mass index regulates hypogonadismassociated CV risk: Results from a cohort of
subjects with erectile dysfunction
Giovanni Corona, Italy
G. Rastrelli, M. Monami, G. Forti, E. Mannucci, M. Maggi
PS-01-006
Diabetes mellitus is associated with penile
shortening
Mustafa Kadihasanoglu, Turkey
M. Aydin, U. Sariogullari, C. Miroglu, M. Ken
dirci
PS-01-007
Incremental value of poor penile arterial inflow for the prediction of significant
coronary artery stenosis in asymptomatic
hypertensive patients with increased carotid intima media thickness: A prospective
angiographic study
N. Ioakeimidis, D. Terentes-Printzios, A. Synodinos, K. Aznaouridis, A. Aggelis, C. Fassoulakis, K. Rokkas, T. Askitis, C. Stefanadis
PS-01-008
Efficacy and safety of topical Aprostadil
Cream (Vitaros®) in hypertensive, diabetic
and cardiac patients with male erectile
dysfunction (ED)
Jacques Buvat, France
J. Schupp, I. Goldstein, B. Damaj, D. Frank,
M. Hachicha
PS-01-009
Sexual function in major depression and
the effect of treatment with gepironeer
Louis F. Fabre, USA
L. C. Smith
Blue Room 2
Male sexual health
Chairpersons:Ian Eardley, United Kingdom
Antonio Martín-Morales, Spain
PS-01-001
Upon normalization of serum testosterone
improvements of features of the metabolic
syndrome are continuous over 48 months.
A study in three cohorts, in total 410 men
Farid Saad, Germany
A. Haider, A. Yassin, M. Zitzmann, L. Gooren, E. Nieschlag
Thyroid hormones and sexual function
F. C. W. Wu, G. Forti, D. Lee, D. B. O’Connor,
T. W. O’Neill, N. Pendleton, G. Bartfai,
S. Boonen, M. Maggi
24
Scientific Program
PS-01-010
Poor response to intracavernous alprostadil
injection test is associated with arteriogenic erectile dysfunction and higher risk of
major adverse cardiovascular events
Giulia Rastrelli, Italy
G. Corona, A. Morelli, L. Vignozzi, E. Mannucci, M. Maggi
PS-01-011
Very long term outcome of a cohort of 542
ED patients under self intracavernous injections
H. Sussman, C. Costa
PS-01-012
Time to onset of action of vardenafil orodispersible and film-coated tablets: A retrospective analysis of the pivotal trials
Frans Debruyne, Netherlands
M. Gittelman, H. Sperling, M. Börner,
M. Beneke
PS-01-013
PS-02
15.30 – 16.30 h
PS-02-001
Testosterone protects from metabolic syndrome-associated prostatitis: An experimental study in rabbit
A. Morelli, P. Comeglio, I. Cellai, S. Filippi,
M. Gacci, F. Saad, L. Adorini, G. Vannelli,
M. Maggi
PS-02-002
Effects of changes in the sex hormone milieu on male’s erectile function in rats
Tomoya Kataoka, Japan
Y. Hotta, A. Shiota, M. Ohno, Y. Maeda,
K. Kimura
PS-02-003
Androgen depletion leads to upregulation of
Sirt1-eNOS axis in human cavernous tissue
Inês Tomada, Portugal
N. Tomada, H. Almeida, D. Neves
PS-02-004
Why erectile dysfunction is highly prevalent and precedes other vascular diseases
is attributable to incompetent cavernous
endothelial cell-cell junction
Jun-Kyu Suh, Republic of Korea
H.-R. Jin, J.-K. Ryu, G. N. Yin, M.-H. Kwon,
K.-M. Song, M. J. Choi, J. S. Lee, W. J. Kim,
W.-S. Chung (presenter)
PS-02-005
Relaxant capacity of PDE5 inhibitors is potentiated by nebivolol in human corpus cavernosum and penile arteries from diabetic
patients with erectile dysfunction
J. I. Martínez-Salamanca, A. Fernández, P.
Cuevas, P. Cardoso, H. M. Wright, J. M. La
Fuente
BSSM Scientific Meeting
RT-01
White Room, Level 2
Round Table
15.30 – 16.30 h
Blue Room 1
PDE5is for ED: What fits best with a couples’ sexual
ecology?
Chairpersons: Konstantinos Hatzimouratidis, Greece
Rossella E. Nappi, Italy
RT-01-001
Stable partner – chronic or p.r.n. PDE5i use?
RT-01-002
What is the optimal regime of PDE5i usage
for a single man?
Ian Eardley, United Kingdom
RT-01-003
The partner‘s perspective
Blue Room 2
Basic science – preclinical research
Chairpersons: Selim Cellek, United Kingdom
Overall treatment response among patients with incomplete response to tadalafil
on-demand: Analysis of pooled data from
17 randomized clinical studies
Allen Seftel, USA
X. Ni, L. McKay
15.00 – 16.30 h
Podium Session
25
Scientific Program
PS-02-006
PS-02-007
PS-02-008
Oral L-citrulline supplementation improves
erectile function in rats with acute arteriogenic erectile dysfunction
Arufumi Shiota, Japan
Y. Hotta, Y. Takahata, T. Kataoka, M. Ohno,
Y. Maeda, M. Morita, T. Hara, K. Kimura
SA-01
16.30 – 17.30 h
PS-02-011
Red Room
Patients‘ perspective on coping with severe ED:
Satisfaction with a permanent solution
Speakers
Antoine Faix, France
David Jones, United Kingdom
Antonio Martin-Morales, Spain
Protein structural alterations in diabetic
cavernosal tissue26 – their role in erectile
dysfunction progression
Angela Castela, Portugal
R. Soares, P. Gomes, P. Coelho, R. Fernandes, R. Costa, P. Vendeira, C. Costa
Topics
Prevalence of ED refractory to medical treatment
Patient perspective and experience after failure of first and
second-line therapies
Expression and distribution of the transient
receptor potential ion channel A1 (TRPA1)
in human penile erectile tissue
Stefan Ückert, Germany
E. Waldkirch, J. Sonnenberg, N. Boeck,
M. Kuczyk, P. Hedlund
Outcomes of penile prosthesis implantation from patient
and partner point of view
Patient and partner satisfaction
Overcoming myths about penile implants
PS-02-009 Neuro-inflammation following cavernous
nerve injury is accompanied by significant
chemokine-gene upregulation in-vivo and
in-vitro
Maarten Albersen, Belgium
J. Berkers, P. Dekoninck, J. Deprest, D. De
Ridder, F. Van der Aa
PS-02-010
Satellite Symposium
Evolution of the penile prostheses after 35+ years of experience
Device more user-friendly for both patient and surgeon
How to communicate with patients about ED and penile
implants
Choosing the right patient
Case histories
Delayed ejaculation in rapid ejaculator rats
by dapoxetine is associated with alteration
in c-Fos expression in brain nuclei
Pierre Clement, France
M. Laurin, S. Compagnie, J. Bernabé, F.
Giuliano
supported by an educational grant from American Medical
Systems B.V.
D-01
Genital bloodflow and bladder function in
a female rat model for nerve-sparing hysterectomy
Fabio Castiglione, Italy
A. Bergamni, F. Benigni, T. Bivalacqua, P. Rigatti, F. Montorsi, P. Hedlund
Debate
17.30 – 18.30 h
Red Room
Adverse events associated with testosterone therapy
Chairperson: John Dean, United Kingdom
Lecturer:
Shezad Basaria, USA
Criticism from the endocrinologist
Andrea Isidori, Italy
PS-02-012 Perioperative systemic betamethasonetreatment in a rat model for nerve-sparing
hysterectomy
A. Bergamini, F. Benigni, T. Bivalacqua, P. Rigatti, F. Montorsi, P. Hedlund
Criticism from the urologist
Abraham Morgentaler, USA
Opening Ceremony
18.30 – 19.30 h
followed by a Welcome Reception from 19.30 h.
26
Red Room
Scientific Program
EC-01
Educational Course
07.30 – 09.00 h
RT-02
Red Room
09.00 – 10.30 h
Andrological emergencies (priapsm, penile fracture, severe genital trauma)
Chairperson:Ates Kadioglu, Turkey
Surgical treatment of penile fracture: Current concept
EC-01-003 Severe genital trauma – emergency treatment in 2011
Miroslav Djordevic, Serbia
EC-02
Blue Room
EC-02-003
EC-02-004
Conservative surgery for penile cancer
Majid Shabbir, United Kingdom
RT-02-002
Severe traumatic penile injuries
RT-02-003
Shunts for priapism – what is best?
RT-02-004
Sexuality-preserving urethroplasty
Enzo Palminteri, Italy
RT-03
Contemporary clinical management of erectile dysfunction: How to practically approach men with cardiological
comorbidities
Chairpersons: Charalambos Vlachopoulos, Greece
Piero Montorsi, Italy
EC-02-002
RT-02-001
Educational Course
07.30 – 09.00 h
EC-02-001
Red Room
Surgery in motion: Common complex problems in clinical practice
Chairpersons: Emanuele Belgrano, Italy
EC-01-001 Current treatment of low-flow, high-flow
and stuttering priapism
Suks Minhas, UK
EC-01-002 Round Table
09.00 – 10.30 h
I am an andrologist: What questions to ask
to my patients, what exams to order?
Avoiding ED in the hypertensive patient:
Tips and tricks
Michalis Doumas, Greece
PDE5 inhibitors in the cardiac patient:
More than ED drugs
Educational Course
07.30 – 09.00 h
EC-03-002
How hormone therapy may help sexual
function at menopause
Santiago Palacios, Spain
Sexuality in patients with body dysmorphic
disorder
David Veale, United Kingdom
RT-03-002
Sexuality in patients with amyotrophic lateral sclerosis
Vincenzo Silani, Italy
RT-03-003
Eating disorders impact on sexual function
Valdo Ricca, Italy
RT-03-004
Psychiatric morbidity and sexuality
Anita H. Clayton, USA
10.30 – 11.00 h
Contraception and HRT for women in contemporary clinical practice
Chairperson:Rossella E. Nappi, Italy
Sexual counseling in contraceptive choice
RT-03-001
ML-01
Yellow Room
EC-03-001
Blue Room
Sexuality in patients with physical and psychiatric disabilities
Chairpersons: Jens Sønksen, Denmark
Is sex dangerous for my cardiac patient?
EC-03
Round Table
Master Lecture
Red Room
Epidemiology and sexual medicine: New challenges and
opportunities
Moderator:
Juan Ignacio Martinez-Salamanca
Lecturer:Raymond C Rosen, USA
27
Scientific Program
PS-01B
HP-01-002 Visfatin impairs endothelium-dependent
relaxation in human penile resistance arteries through nicotinamide phophoribosyl
transferase (NAMPT) activity
J. M. La Fuente, C. F. Sánchez-Ferrer,
A. Fernández, T. Romacho, P. Cuevas,
R. Carraro, C. Peiró
Master Lecture
10.30 – 11.00 h
Blue Room
Male sexual health
Chairpersons: Carlo Trombetta, Italy
Francesco Sasso, Italy
PS-01B-014 12 weeks of treatment with tadalafil as
needed significantly improves ejaculatory
and orgasmic dysfunction in men enrolled
in 17 placebo-controlled studies of erectile
dysfunction
Darius Paduch, USA
A. Bolyakov, P. Polzer, S. Watts
HP-01-003 Hypersaline sodium-rich carbonated natural mineral water consumption modify
structure and expression of angiogenic
factors in corpus cavernosum of fructosetreated rats
Delminda Neves, Portugal
I. Tomada (presenter), C. Pereira, R. Monteiro, M. J. Martins
PS-01B-016 Premature ejaculation: A prospective randomized study to compare pelvic floor rehabilitation and dapoxetine, a novel selective serotonin reuptake inhibitor
Antonio Luigi Pastore, Italy
G. Palleschi, L. Silvestri, A. Ripoli, D. Autieri,
A. Leto, A. Carbone
HP-01-004 Clinical, biochemical and male genital
tract colour-doppler ultrasound correlates
of seminal vesicles static and dynamic ultrasound features in men attending an andrology clinic for infertility
Francesco Lotti, Italy
G. Corona, G. M. Colpi, E. Filimberti, S. Degli Innocenti, M. Mancini, E. Baldi, I. Noci,
G. Forti, M. Maggi (former PO-15-016)
PS-01B-017 Perceived ejaculate volume reduction in
patients with erectile dysfunction: Psychobiological correlates
G. Corona, V. Boddi, F. Paggi, G. Balercia,
G. Forti, E. Mannucci, M. Maggi
PS-01B-018 Is there a correlation between premature
ejaculation and the female partner’s sexual
function?
Gila Bronner, Israel
N. Kitry, G. Raviv, J. Ramon, E. Elran
HP-01
HP-01-005
The cyclic AMP-binding protein kinase A
(cAK) is co-localized with vasoactive intestinal polypeptide in the human vagina
Stefan Ückert, Germany
W. Kauffels, M. Kuczyk, P. Hedlund
HP-01-006
Dopamine modulates reward system activity
during subconscious processing of sexual
stimuli
Stephanie Both, Netherlands
N. Oei, S. Rombouts, R. Soeter, J. van Gerven
HP-01-007
Gender-related differences in rat bladder
PDE5 biological and catalytic activity
S. Filippi, A. Morelli, P. Comeglio, R. Mancina, M. Gacci, M. Carini, M. Maggi
HP-01-008
Phosphodiesterase type 5 is expressed in
human and rat lower urinary tract tissues
and its inhibition with tadalafil improves
prostate gland oxygenation in spontaneously hypertensive rats
Annamaria Morelli, Italy
E. Sarchielli, P. Comeglio, S. Filippi, R.
Mancina, M. Gacci, L. Vignozzi (presenter),
M. Carini, G. B. Vannelli, M. Maggi
Highlighted Poster Session
11.00 – 11.30 h
Exhibition Hall B
Basic science – preclinical research
Chairpersons: Javier Angulo, Spain
HP-01-001
Effect of mescenchymal derived stem cells
using matrixen on the erectile function in
the rat model with bilateral cavernous nerve crushing injury
Su Jin Kim, Republic of Korea
T. Y. Ahn, W. J. Bae, Y. S. Choi, H. J. Cho, S.
H. Hong, J. Y. Lee, T.-K. Hwang, S. W. Kim
11.00 – 11.30 h Coffee break
28
Scientific Program
HP-02
11.00 – 11.30 h
RT-04
Exhibition Hall B
Round Table
11.30 – 12.25 h
Red Room
Psychosexual issues
Chairpersons: Stuart Brody, United Kingdom
HPV awareness in men
Chairpersons: Carlo Foresta, Italy
David Goldmeier, United Kingdom
HP-02-001
Tiresias (types of sexual response and substance addiction)
Francisco Javier Del Río Olvera, Spain
F. Cabello Santamaría
RT-04-001
Male genital and extragenital HPV prevalence and associated factors
Joel M. Palefsky, USA
RT-04-002
HP-02-002
Sexual and reproductive health and condom discomfort among students: An exploratory study
Stamatis Papaharitou, Greece
G. Giaglis, M. Moraitou, D. Hatzichristou
Efficacy of the HPV vaccine in men
Stephen Goldstone, USA
RT-04-003
Economic implications of HPV vaccination
in the male gender
Livio Garattini, Italy
HP-02-003
HP-02-004
Is current public awareness of human papilloma virus sufficient in the web-networking generation?
Antonino Sacca, Italy
A. Salonia, F. Abdollah, R. Matloob, D. Moretti, M. Ferrari, F. Castiglione, G. Castagna,
M. C. Clementi, P. Rigatti, F. Montorsi
RT-05
11.30 – 12.30 h
Sexual and reproductive health and media
use: An exploration of female young students‘ HIV / STDs knowledge
Stamatis Papaharitou, Greece
E. Nakopoulou, M. Moraitou, D. Hatzichristou
Sexual dysfunction and depression
Sevada Hakobyan, Armenia
HP-02-008
The re-establishment of organic and erotic
functions in penile prosthesis implanta
tion: Which relation?
Annamaria Abbona, Italy
F. Peraldo, F. Pisano, F. Soria, C. Fiorito,
P. Gontero
RT-05-001
Endometriosis & deep dyspareunia
Paolo Vercellini, Italy
RT-05-002
Hormonal contraception: Against endometriosis and impaired sex life
Adolf E. Schindler, Germany
RT-05-003
Protection of sexual function in the surgical management of endometriosis
Simone Ferrero, Italy
SA-02
Luncheon Symposium
12.30 – 13.30 h
Male cancers and specific requests for sexual care: Lessons for daily practice based
on 3 prospective surveys in an outpatient
urology clinic in a public hospital
Pierre Bondil, France
D. Habold, T. Damiano
HP-02-007
Blue Room
Endometriosis and female sexuality
Chairpersons: Johannes Bitzer, Switzerland
Stefano Salvatore, Italy
HP-02-005 Heterosexual anal intercourse is increasing in prevalence, and is associated with
bisexual behavior and history of venereal
disease, and female sexual dysfunction
Petr Weiss, Czech Republic
S. Brody
HP-02-006
Round Table
Red Room
Why What When: Facets of human sexuality – from evolutionary to treatment success
Chairperson: Ian Eardley, United Kingdom
SA-02-001
Why do we have sex? Biological evolution
of human sexuality
Dietrich Klusmann, Germany
SA-02-002
What are the myths and facts of our sexual
behaviour?
SA-02-003
When sexual life is in trouble – why “back
to normal?”
Ian Eardley, United Kingdom
supported by an educational grant from Eli Lilly and Company.
29
Scientific Program
RT-06
Round Table
13.30 – 15.00 h
SA-04
Red Room
15.00 – 16.00 h Sexual health and pelvic disease
Chairpersons:Ilan Gruenwald, Israel
Alessandro Zucchi, Italy
Overactive bladder and sexual fuction in
women: A critical reappraisal
Eduard Cortes, United Kingdom
RT-06-002
Lower urinary tract symptoms and male sexuality
François Giuliano, France
RT-06-003
Pelvic health and sexual dysfunction in the
everyday clinical practice?
Lior Lowenstein, Israel
RT-06-004
How may comorbid conditions impact on
pelvic health?
Anastasios Athanasopoulos, Greece
SA-04-001
Treatment of erectile dysfunction: recognizing the unmet needs
Dimitris Hatzichristou, Greece
SA-04-002
How to treat ED patient with Low intensity
shock wave
Boaz Appel, Israel
SA-04-003
Low intensity shock wave therapy for erectile dysfunction: Results of clinical trials
Yoram Vardi, Israel
Questions and Answers
supported by an educational grant from Medispec Ltd.
HP-03
Round Table
13.30 – 15.00 h
Blue Room
Groundbreaking treatment for Erectile Dysfunction using
EDSWT (Erectile Dysfunction Shock Wave Therapy)
RT-06-001
RT-07
Satelliite Symposium
15.00 – 15.30 h
Blue Room
Women‘s sexual health
Chairpersons:Rossella E. Nappi, Italy
Protection of intellectual property
Chairpersons: Marcel D. Waldinger, The Netherlands
RT-07-001
Intellectual property – Can I legally protect
my bio-ideas?
Giulio E. Sironi, Italy
RT-07-002
Can a pharmaceutical company protect its
new compounds?
Michael G. Wyllie, United Kingdom
RT-07-003
How can scientific and intellectual honesty
be assured?
RT-07-004
Can intellectual contents be protected in
sexual medicine – The role of the scientific
societies
Edgardo Becher, Argentina
Exhibition Hall B
30
HP-03-001
Alexithymia and vaginismus: A correlation
perspective
Giacomo Ciocca, Italy
E. Limoncin, G. L. Gravina, E. Carosa, S. Di
Sante, S. Di Tommaso, A. Lenzi, L. Gandini,
A. M. Isidori, E. A. Jannini
HP-03-002
Sexuality of women with polycystic ovary
syndrome
Violetta Skrzypulec-Plinta, Poland
R. Kowalczyk, A. Skrzypulec
Scientific Program
HP-03-003
HP-03-004
HP-03-005
Sexual function impact of stress urinary incontinence surgical treatment: Comparison
between mid-urethral and single-incision
slings
Tiago Lopes, Portugal
A. Resende, R. Oliveira, R. Pinto, F. Botelho,
N. Tomada, C. Francisco, P. Vendeira
HP-04
15.00 – 15.30 h
Exhibition Hall B
Surgery and sexual dysfunction
Chairpersons: Wayne Hellstrom, USA
Sexual function in premenopausal morbid
obese women with obstructive sleep apnea
syndrome
Antonella Camera, Italy
A. Camera, F. Fanfulla, L. Chiovato, R. E.
Nappi
The impact of parental bonding on FSD in
women with type 1 diabetes: Preliminary
results from a pilot study
Konstantinos Dimitropoulos, Greece
A. Bargiota, O. Mouzas, V. Tzortzis, G. Koukoulis
HP-04-001
Effective antibiotic dips for the coloplast
titan penile implant
Cesar Rojas-Cruz, Spain
S. Wilson
HP-04-002
Clinical result of venous ligation surgery in
erectile dysfunction patient
Joon Yong Kim, Republic of Korea
HP-04-003 Patient satisfaction and complications
with the titan® one touch release (otr) penis prosthesis
Lisa Lindeborg, Denmark
M. Fode, L. Fahrenkrug, J. Sønksen
HP-03-006
Weight loss impact on young adult active
female sexual life
Dana Stoian, Romania
M. Craina, D. Anastasiu
HP-04-004
The status of sexual function in patients
with peyronie‘s disease
Igor Gorpynchenko, Ukraine
Y. Gurzhenko, R. Maksym
HP-03-007
Body image and sexual function in Turkish
women compared to Turkish men: Internet
survey results
E. Hattat, I. Hattat
HP-04-005
Duration of disease has significant impact
on ED occurrence in patients with induratio penis plastica
Djordje Nale, Serbia
N. Bojanic, P. Nikic, C. Tulic
HP-03-008
Age group analysis of a randomized, double-blind, phase 3 study of Femprox®,
a topical alprostadil cream with a novel
transdermal delivery technology (nexact®)
for the treatment of female sexual arousal
disorder (FSAD)
Y. Fernando, I. Goldstein, B. Damaj, D. Frank,
M. Hachicha, Y. Fernando, J. Schupp
HP-04-006
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in
patients with penile carcinoma
Gaetano Gulino, Italy
F. Sasso, G. Palermo, F. Pinto, A. d´Onofrio,
E. Sacco, M. Racioppi, P. Bassi
HP-04-007
Total phalloplasty combined with metoidioplasty as a one-stage procedure in female
transsexuals: Is it possible?
Miroslav Djordjevic, Serbia
D. Stanojevic, V. Kojovic, M. Bizic, M. Maj
storovic
HP-04-008
Minimally invasive surgery for penile augmentation using type I collagen
Tae Kyoung Yun, Republic of Korea
H. S. Jeon, D. W. Sohn
31
Scientific Program
PS-03
Podium Session
16.00 – 16.30 h
PS-04
Red Room
Podium Session
16.00 – 16.30 h
Blue Room
Chairperson: Christina Damsted Petersen, Denmark
Paraskevi-Sofia Kirana, Greece
Surgery
Chairpersons: Luigi C. Cormio, Italy
David Ralph, United Kingdom
PS-03-001
Clinical approach to anorgasmia in women
with spinal cord injury
Frédérique Courtois, Canada
K. Charvier, D. Bélanger, J.-G. Vézina, I. Coté,
M. Boulet, S. Carrier, G. Jacquemin
PS-04-001
PS-03-002
Autoimmune thyroiditis – impact on sexual
wellbeing in premenopausal women
Dana Stoian, Romania
D. Anastasiu, M. Craina
Orgasmic function and lubrication of the
neo-vagina: Comparison between two techniques of vaginoplasty in male to female
sex reassignment surgery
C. V. Pultrone, B. Barbieri, G. Gentile, E. Bru
nocilla, A. Franceschelli
PS-04-002
Multicentric study of reconstructive technique of the glans after partial penectomy
for squamous cell carcinoma
Rosario Leonardi, Italy
S. Pecoraro, S. Sansalone, M. Silvani, A.
Zucchi
PS-04-003
Vacuum therapy for Peyronie’s deformity:
An effective and viable alternative to surgery
Sudhanshu Chitale, United Kingdom
K. Sethia
PS-04-004
Excision of elliptic fragment of external
layer of tunica albuginea as a new, littleinvasive method of operative treatment of
congenital penile curvature – late results
Wojciech Perdzynski, Poland
M. Adamek
PS-04-005
The outcomes of the T shunt procedure
and Intracavernous Tunneling (snake manouver) for the management of the ischaemic priapism
Evangelos Zacharakis, United Kingdom
A. Muneer, A. Skolarikos, S. Minhas, A. Papatsoris, C. Deliveliotis, D. Ralph
PS-04-006
Coated implants and “no touch” surgical
technique decreases risk of infection in
inflatable penile prosthesis implantation to
0.46 %
J Francoise Eid, USA
S. Wilson
PS-03-003
Automatic sexual associations ‘predict’ hypothalamus activity in healthy women exposed to explicit pornography
Charmaine Borg, Netherlands
P. de Jong, J. Georgiadis
PS-03-004 Effects of hormonal contraception on
women’s sexual function: A cross-sectional
study in a cohort of Danish women
Nanna Læssøe, Denmark
S. Wåhlin, E. Kristensen, A. Giraldi, A. T. Pedersen
PS-03-005
PS-03-006
Sexual function in Bulgarian patients with
PCOS and/or obesity before and after metformin treatment
Antoaneta Gateva, Bulgaria
Z. Kamenov
What role plays female sexual dysfunction
in the gynaecologist daily routine?
Andreas Kottmel, Switzerland
K. Rüther, J. Bitzer
32
Scientific Program
RT-08
Round Table
16.30 – 17.30 h
EC-05
Red Room
17.30 – 19.00 h
Men’s health – understanding the role of testosterone
Chairpersons: Jacques Buvat, France
Mario Maggi, Italy
RT-08-001
The genomic effect of testosterone upon
men‘s health
Michael Zitzmann, Germany
RT-08-002
Evidence and implications of testosterone
deficiency in ageing men with sexual dysfunction – the European Male Ageing Study
Frederick Wu, United Kingdom
RT-08-003
Classic concepts of urology revisited: Is testosterone really dangerous for the prostate?
Abraham Morgentaler, USA
RT-09-002
RT-09-003
The impact of benign gynaecological disorders on female sexual function
EC-05-003
Gynecological and breast cancer – sexual
life of the survivors
Symposium
Testosterone replacement treatment: chi, come quando?
Urologo e testosterone
Carlo Bettocchi, Italy
Sexual benefits of hormonal contraception:
fact or fiction?
Testosterone e tumore della prostata
Vincenzo Gentile, Italy
Educational Course
Red Room
Gender reassignment surgery
Chairperson:David Ralph, United Kingdom
EC-04-001
Management of male to female reassignment
Carlo Bettocchi, Italy
EC-04-002
Management of female to male reassignment
Christopher Nim, United Kingdom
EC-04-003
Non genital surgery
Giulio Garaffa, United Kingdom
Yellow Room
Cosa é il testosterone per il maschio?
Acceptability of contraception for men
Eberhard Nieschlag, Germany
17.30 – 19.00 h
EC-05-002
Italians@ESSM 2011 – Italian language
Testosterone = tumore della prostata!
Chairpersons: Mario Maggi, Italy
Giuseppe Morgia, Italy
Blue Room
When are oral contraceptive pills indicated
in adolenscence?
EC-04
How do gynecological disorders impact female sexual function: Main pathophysiological pathways
17.30 – 19.00 h
Contraception versus sexuality: Who is the winner?
Chairpersons:Alessandra Graziottin, Italy
Onder Yaman, Turkey
RT-09-001
EC-05-001
SIT-02
Round Table
16.30 – 17.30 h
Blue Room
Gynaecological disorders in sexual medicine
Chairperson: Johannes Bitzer, Switzerland
Supported by an educational grant from Pierre Fabre Médicament
RT-09
Educational Course
33
Scientific Program
EC-06
Educational Course
07.30 – 09.00 h
RT-10
Red Room
09.00 – 10.30 h
What the sexual physician needs to know about sexually
transmitted infections
Chairperson:David Goldmeier, United Kingdom
EC-06-001
EC-06-002
Sexually transmitted infections – their relevance to your patients
Jane Ashby, United Kingdom
Educational Course
07.30 – 09.00 h
EC-07-002
RT-10-001
When to start sex after a myocardial infarction?
RT-10-002
Cardiovascular drugs and erectile dysfunction. The good, the bad and the ugly
RT-10-03
PDE5 inhibitors in cardiac patients
RT-10-004
Testosterone supplements and the cardiovascular system
Mario Maggi, Italy
Blue Room
The role of penile prosthesis in contemporary sexual
medicine practice
Chairperson: Carlo Bettocchi, Italy
EC-07-001
Red Room
Sexual activity after a myocardial infarction: A sweet
hereafter?
Chairpersons: Manuel Mas, Spain
Sexually transmitted infections – the facts
Ali Mears, United Kingdom
EC-07
Round Table
The correct choice: prosthesis and surgical
approach
RT-11
Round Table
09.00 – 10.30 h
Difficult implants
Blue Room
Practical management of surgical complications
Chairpersons:Fulvio Colombo, Italy
Emre Akkus, Turkey
EC-07-003
Case reports on implants
David Ralph, United Kingdom
EC-07-004
Complications and patient satisfaction
Antoine Faix, France
RT-11-001
The prevention of penile shortening after
grafting surgery for peyronie‘s disease
Giulio Garaffa, United Kingdom
RT-11-002
Genital skin loss
Yellow Room
RT-11-003
Contemporary clinical management of male testosterone deficiency syndrome – a practical approach in the
everyday clinical practice
Chairperson
and Lecturer: Mario Maggi, Italy
Updated management of an infected penile implant
Mustafa Faruk Usta, Turkey
RT-11-004
The management of penile augmentation
complications
RT-11-005
The management of the cosmic surgical
complications of male to female surgery
Edoardo Austoni, Italy
EC-08
07.30 – 09.00 h
Educational Course
34
Scientific Program
ML-03
Master Lecture
10.30 – 11.00 h
HP-05-006
Baseline factors associated with incomplete response to tadalafil on-demand: Analysis of pooled data from 17 randomized
clinical studies
Allen Seftel, USA
X. Ni, L. McKay
Master Lecture
10.30 – 11.00 h
Blue Room
History lecture@ESSM
Moderator: Dirk Schultheiss, Germany
HP-05-007 Low-intensity extracorporeal shock wave
therapy for erectile dysfunction in phosphodiesterase-5 inhibitor responders: A ran
domized, double-blind, placebo-controlled
study
I. Gruenwald, Israel
Y. Vardi, B. Appel, E. Gerber, E. Sprecher,
A. Kilchevsky, Omar Massarwi
The seductiveness of 'Arte Povera'
Lecturer:
Germano Celant, Italy
HP-05
The real-life perception of efficacy, attitude,
satisfaction and safety of vardenafil therapy
(REPEAT): A prospective, international, multicentre, non-interventional study
Uwe Hartmann, Germany
J. U. Hanisch, A. Mattern (presenter)
Red Room
ISSM lecture: Quaternary prevention in sexual medicine:
Can we avoid harmful treatments?
Moderator:
Muammer Kendirci, Turkey
Lecturer:
Chris McMahon, Australia
ML-04
HP-05-005
11.00 – 11.30 h
Exhibition Hall B
HP-05-008
Male sexual health
Chairpersons: Konstantinos Hatzimouratidis, Greece
Arik Shechter, Israel
HP-05-001
HP-05-002
The gay men sex studies: Erectile dysfunction among Belgian gay men
Johan Vansintejan, Belgium
D. Devroey, J. Vandevoorde
Perceived reduced sleep-related erections
in subjects with erectile dysfunction: Psycho-biological correlates
G. Rastrelli, G. Balercia, G. Forti, E. Mannucci, M. Maggi
HP-06
11.00 – 11.30 h
Exhibition Hall B
Men‘s sexual health and ejaculatory disorders
Chairpersons: Jens Sønksen, Denmark
HP-05-003 Androgen deficiency: A critical determinant of aortic stiffness in men with erectile
dysfunction
C. Vlachopoulos, A. Samentzas, D. TerentesPrintzios, P. Xaplanteris, K. Rokkas, C. Fas
soulakis, T. Askitis, A. Rempelakos, C. Stefanadis
HP-05-004
Determinants of increased cardiovascular
risk in men <60; 50 years of age with erectile dysfunction
Athanasios Aggelis, Greece
C. Vlachopoulos, N. Ioakeimidis, D. TerentesPrintzios, A. Synodinos, K. Rokkas, T. Askitis,
C. Stefanadis
HP-06-001
An open-label, long-term evaluation of the
safety and tolerability of avanafil in men
with erectile dysfunction
Laurence Belkoff, USA
A. McCullough, I. Goldstein, K. Di Donato,
B. Trask, C. Bowden
35
Ejaculatory duct obstruction, an important
cause of ejaculatory disorders
Amr Raheem, United Kingdom
E. Zacharakis, F. De Luca, M. Walkden,
C. Allen, D. Ralph
Scientific Program
HP-06-002
HP-06-003
HP-06-004
HP-06-005
Therapy for pulmonary tuberculosis as a
reason for ejaculatory disorders
Ekaterina Kulchavenya, Russia
S. Medvedev
RT-12
11.30 – 12.25 h
Red Room
Sexually transmitted diseases: Stay vigilant!
Chairpersons:David Goldmeier, United Kingdom
Alexithymia and delayed ejaculation: A con
tribute to understand a neglected sexual
dysfunction
Paolo Maria Michetti, Italy
S. Eleuteri, M. Giuliani, R. Pinto, R. Rossi,
C. Leonardo, G. Franco, C. De Dominicis,
C. Simonelli
Polymorphisms in the serotonin 1B receptor gene are associated with self-reported
ejaculation latency time
Patrick Jern, Finland
L. Westberg, A. Johansson, A. Gunst, E. Erik
sson, N. K. Sandnabba, P. Santtila
RT-12-001
Have we finally eradicated „old-fashioned“
STDs?
Philip Kell, United Kingdom
RT-12-002
HIV in 2011 – Prevention and research
Sheena McCormack, United Kingdom
RT-12-003
Strategies for intervention on social determinants of infectious diseases
Jan Semenza, Sweden
RT-13
Eiaculatio praecox worsens the sexual distress perceived by female partner
Erika Limoncin, Italy
M. Tommassetti, G. L. Gravina, G. Ciocca,
E. Carosa, A. M. Isidori, A. Lenzi, E. A. Jannini
Round Table
11.30 – 12.30 h
Blue Room
Preclinical research in 2011 – is pipeline empty?
Chairpersons: Javier Angulo, Spain
Carla Costa, Portugal
HP-06-006 The relationship between lower urinary
tract symptoms (LUTS) and premature ejaculation (PE) in Korean men
Kweon-Sik Min, Republic of Korea
J. Um, J. Yoon, D. Kang, K.-S. Cho
HP-06-007
Round Table
The clinical significance of stopwatch intravaginal ejaculation delay time (IELT) and
correlation with self reported IELT: Results
from national representative sampling
Sung Won Lee, Republic of Korea
J. H. Lee, H. J. Park, J. K. Park, K. Park,
S. Choi, S. C. Kam
36
RT-13-001
Research innovation in the treatment of
erectice dysfunction
RT-13-002
Research innovation in the treatment of
female sexual dysfunction
RT-13-003
Translation and validation in sexual medical science – need for standardisation of
preclinical research?
Selim Cellek, United Kingdom
Scientific Program
SA-03
Luncheon Symposium
12.30 – 13.30 h
RT-15
Red Room
13.30 – 15.00 h
Men's changing sexuality, identity and behaviour
Chairperson: Francesco Montorsi, Italy
12.30 h
Introduction
12.40 h
Panel discussion
Moderator: Francesco Montorsi, Italy
Stanley Althof, USA
Frans Debruyne, The Netherlands
13.25 h
supported by an educational grant from Bayer HealthCare
Pharmaceuticals
Round Table
13.30 – 15.00 h
Blue Room
Onco-sexual medicine – only a neologism or a new concept?
Chairpersons: Paolo Gontero, Italy
Luca Incrocci, The Netherlands
Concluding remarks
RT-14
Round Table
RT-15-001
Sexual function in people with severe disabilities from cancer
Woet L. Gianotten, Netherlands
RT-15-002
Sexual dignity after prostate cancer – more
than an erection!
John P. Mulhall, USA
RT-15-003
Sexuality of patients with a stoma
Scott M. Gilbert, USA
RT-15-004
Psychological interventions for the sexual
sequelae of cancer
Lori Anne Brotto, Canada
Red Room
Sexuality in the elderly
Chairpersons:Antonio Martin Morales, Spain
Pedro Simoes Vendeira, Portugal
HP-07
15.00 – 15.30 h
Exhibition Hall B
RT-14-001
Prevalence of sexual activity and associated factors in the elderly
Surgical potpourri
Chairpersons:Natalio Cruz, Spain
Dirk Schultheiss, Germany
RT-14-002
Lifestyle practices and cardiovascular diseases in the elderly
Kornelia Kotseva, United Kingdom
HP-07-001
RT-14-003
Can a good sex life reduce depression in
later life?
Evan Atlantis, Australia
The effects of ozone therapy on cavernosal
damage due to ischemia / reperfusion injury
induced priapism in rat models
Murad Basar, Turkey
T. Aydos, O. Kul, T. Atmaca, T. Uzunalioglu,
U. Kisa
RT-14-004
Sexual satisfaction and relationship happiness in older couples – fact or fiction?
Raymond C Rosen, USA
HP-07-002
Distal corpus cavernosum smooth muscle
fibrosis due to non-ischaemic priapismshould embolisation be performed earlier?
M. Shabbir, M. Walkden, S. Minhas, D. Ralph,
A. Muneer
37
Scientific Program
HP-07-003
Re-do vaginoplasty with sigmoid colon in
male transsexuals
Marta Bizic, Serbia
D. Stanojevic, S. Vujovic, M. Djordjevic
HP-07-004
Urethral reconstruction in metoidioplasty
(female to male transsexual surgery): Comparison of three different methods
Vladimir Kojovic, Serbia
D. Stanojevic, M. Bizic, M. Majstorovic, M.
Djordjevic
HP-07-005
Two year follow-up of plaque incision and
plication to correct Peyronies disease
Hubert Claes, Belgium
H. Van Poppel
Penile prosthesis insertion in gender dysphoria-long term results
Donato Dente, Italy
G. Garaffa, A. Kayes, N. Christopher, D. Ralph
HP-07-008
Penile lengthening for adult contractile penis preserving suspensory ligament
Tae Kyoung Yun, Republic of Korea
H. S. Jeon, D. W. Sohn
HP-08
HP-08-004
Priapus is happier with Venus than with
Bacchus
Valentina Boddi, Italy
G. Corona, M. Monami, A. Fisher, E. Bandini, C. Melani, D. Balzi, V. Patussi, G. Forti,
E. Mannucci, M. Maggi
HP-08-006
A 6-month prospective observational study
of PDE5 inhibitor treatment persistence
and adherence in Latin American men with
erectile dysfunction: The PROACT study
Eusebio Rubio-Aurioles, Mexico
L. A. Reyes Vallejo, Y. Lei, S. Sorsaburu
HP-08-007
Association of sexual dysfunction with global health-related quality of life in female
patients with rheumatic diseases
Panagiota Anyfanti, Greece
A. Triantafyllou, G. Triantafyllou, E. Gavriilaki, A. Pyrpasopoulou, S. Chatzimichailidou,
E. Christaki, A. Glystra, S. Douma, S. Aslanidis, M. Doumas (presenter)
15.00 – 15.30 h
Exhibition Hall B
Sexual potpourri
Chairpersons:Antonio Aversa, Italy
Stefan Arver, Sweden
HP-08-001
Short stature is associated with severity of
erectile dysfunction
C. Vlachopoulos, N. Ioakeimidis, D. Terentes-Printzios, A. Synodinos, A. Samentzas,
A. Aggelis, P. Xaplanteris, T. Askitis, C. Stefanadis
HP-08-005 The HhlpED study: Impact of erection
hardness on erection maintenance and
sexual quality of life in men with erectile
dysfunction and especially their partners
A. Albert, R. Opsomer, R. Andrianne, S. Patel, K. Commers
HP-07-006 Surgical management of penile fracture
and long-term outcome – results of a prospective study
Georgios Hatzichristodoulou, Germany
A. Dorstewitz, J. Gschwend, K. Herkommer,
N. Zantl
HP-07-007
HP-08-003
HP-08-008 POIS: An anxiety related psychosomatic
disorder or semen allergy?
Josef van Eyle, United Kingdom
D. Goldmeier, S. Seneviratne
Effects of long-acting testosterone undecanoate on bone mineral density in middle
aged men with late-onset hypogonadism
and metabolic syndrome: Results from a
36 months controlled study
R. Bruzziches, D. Francomano, E. Greco,
R. Fornari, L. DiLuigi, A. Lenzi, S. Migliaccio
ML-05
Master Lecture
15.30 – 16.00 h
Red Room
The „Sandra Leiblum“ lecture on women‘s sexual health
Moderator: Nicolae Calomfirescu, Romania
HP-08-002 Assessing quality of life via aging male
symptoms (AMS) scale after treatment with
intramuscular long-acting testosterone
Christopher C. K. Ho, Malaysia
S. F. Tong, W. Y. Low, C. J. Ng, E. M. Khoo,
V. K. M. Lee, Z. Md Zainuddin, H. M. Tan
Why do you think we should suffer in silence?
Lecturer:Alessandra Graziottin, Italy
38
Scientific Program
ML-06
EC-09
Master Lecture
15.30 – 16.00 h
17.00 – 18.30 h
Blue Room
Red Room
Genital dermatology
Chairperson:Asif Muneer, United Kingdom
Lecturers:
Johannes Blitzer, Switzerland
Asif Muneer, United Kingdom
Chris Bunker, United Kingdom
The importance of a „smile“ in sex
Moderator:
Lecturer:Benedict C. Jones, United Kingdom
RT-16
Educational Course
Round Table
16.00 – 17.00 h
Red Room
EC-10
Common sexual problems that are still difficult to treat
Chairpersons: Juza Chen, Israel
Edouard Amar, France
RT-16-01
The management of non hormone-dependent hypoactive sexual desire
Barry McCarthy, USA
RT-16-02
Treatment of subjectively unsatisfactory
erections
Dimitris Hatzichristou, Greece
RT-16-03
My orgasm and ejaculation is fading – Doc
can you help me?
Selahittin Cayan, Turkey
RT-17
17.00 – 18.30 h
Blue Room
Contemporary clinical management of women‘s sexual
problems: A practical approach in the everyday clinical
practice
Chairperson:Annamaria Giraldi, Denmark
Round Table
16.00 – 17.00 h
Educational Course
EC-10-001
Prevalence and risk factors of sexual problems in women
EC-10-002 Women with sexual pain – a clinical approach
EC-10-003
Assesment of sexual problems in women –
a bio-psycho-social approach
Cases
Interactive discusion
Blue Room
Cultural differences may significantly impact treatment
offered
Chairpersons: Kevan Wylie, United Kingdom
17.00 – 18.30 h
RT-17-001
Italians@ESSM 2011 – Italian language
RT-17-002
RT-17-003
SIT-03
How culturefactors affects young people's
sexual practice
Cicely Marston, United Kingdom
Symposium
Sesso, educazione, comunicazione e web
Chairpersons:Angela Vita, Italy
Protection of sexual dignity in transnational immigrants
Beata Cybulska, United Kingdom
Educazione al sesso e alla sessualità
How mass media influences our sex life
Marie Chevret-Measson, France
Comunicazione con i pazienti
Sesso e web
Carlo Foresta, Italy
Sesso e mass media
39
Yellow Room
Scientific Program
ls-01
SESSION 2
Chairpersons in the Red Room
Luigi Cormio, italy
natalio Cruz, Spain
lIVe suRGeRy sessIOn
07.30 – 12.30 h
Red Room
Live Surgery from the operating rooms of the
department of Urology, University Vita-Salute
San raffaele
director Prof. Patrizio rigatti
Milan, italy
Operating Room 1
Chairperson from Operating Room 1
fabrizio Palumbo, italy
Case #2
Surgeon
Juan ignacio Martínez-Salamanca, Spain
Is andrological surgery heritage of young surgeons?
Supervisor from the operating rooms
federico dehò, italy
SESSION 1
Chairpersons in the Red Room
Edoardo austoni, italy
dirk Schultheiss, germany
10.00-12.30
Tutor
ignacio Moncada, Spain
07.30-10.00
Operating Room 2
fernando fusco, italy
Operating Room 1
fabrizio Palumbo, italy
Case #2
Surgeon
Selahittin Çayan, Turkey
Case #1
Surgeon
giulio garaffa, United Kingdom
Tutor
ates Kadioglu, Turkey
Tutor
david J. ralph, United Kingdom
supported by an unrestricted grant from Porgès-Coloplast
Operating Room 2
fernando fusco, italy
Please visit the exhibition
and poster exhibition open
Case #1
Surgeon
antonino Saccà, italy
from 09.00 – 12.30 h
Tutor
francesco Montorsi, italy
40
Scientific Program
Rt-18
ROunD taBle
09.00 – 10.00 h
Rt-19
Blue Room
11.00 – 12.00 h
Drugs are dangerous for women’s sexual health!
Chairpersons: Marie Chevret-Measson, france
annamaria giraldi, denmark
RT-18-001
Sex-specific differences in sexual side
effects of psychotropic drugs: Genes or
gender?
anita h. Clayton, USa
RT-18-002
The impact of cardiovascular treatments
upon women‘s sexuality
Michalis doumas, greece
RT-18-003
HRT crisis and consequences on population health
Santiago Palacios, Spain
esHa-01
ROunD taBle
Blue Room
Breast cancer: The quality of life and effect on sexuality
of young women
Chairpersons: Lori anne brotto, Canada
nicoletta biglia, italy
RT-19-001
Sex hormones relate to women‘s quality of
life – what‘s the impact of breast health?
nicoletta biglia, italy
RT-19-002
Breast-conserving surgery in young women
oreste gentilini, italy
RT-19-003
Chemotherapy in young women
hatem a. azim, belgium
ROunD taBle
10.00 – 11.00 h
Blue Room
coffee in the
exhibition hall is served
ESHA Session: How does the ED couple deal with fake
medicines: A clinical perspective
Fake medicines 'friend or foe'
irem hattat, Turkey
from 09.00 – 12.00 h
Listen to me doctor – case study
Ece hattat, Turkey and actors
Listening to ED patient and tackling the problem of counterfeit medication
John dean, United Kingdom
41
Scientific Program
ABC Master Course (18 hours)
open to all registered congress delegates
Part I
ABC Master Course
Part II
09.00 –12.20 h
Yellow Room
ABC Master Course
13.30 –16.20 h
Sexuality
Yellow Room
Sexuality
Sexual development and orientation 09.00 – 10.00 h
09.00 h
Sexual differentiation and
development and related disorders
Sexual identity disorders
John Dean, United Kingdom
09.30 h
Human sexual orientation
Kevan Wylie, United Kingdom
09.45 h
Social and cultural factors
Woet L. Gianotten, The Netherlands
Sexual response
Physiological factors
Woet L. Gianotten, The Netherlands
10.15 h
Psychological factors Environmental
(ethical, cutural, religious) factors
Normal sexual development and response
10.55 h
Pubertas precox/early puberty
Pubertas tarda/delayed puberty
Aging men
11.30 h
Aging women
14.00 – 15.00 h
14.00 h
Male hypoactive sexual desire (Libido)
disorders
a) Prevalence and predictors
b) Risk factors
c) Medical treatment
d) Psychological treatment
14.30 h
Hypersexual disorder
14.45 h
Variant sexual behaviours
Ejaculatory and orgasmic disorders
15.00 – 16.20 h
15.00 h
Premature ejaculation (PE)
a) Classification
b) Prevalence and predictors
c) Risk factors
d) Psychological treatments
Patrick Jern, Finland
15.30 h
Medical treatment for PE
Marcel D. Waldinger, The Netherlands
15.45 h
Anorgasmia and delayed or absent
ejaculation
a) Classification
c) Risk factors
d) Treatment options
Stuart Brody, United Kingdom
11.45 h
Romance and sexual relationship in
elderly
Sexual violence (male and female) – paraphilias Woet L. Gianotten, The Netherlands
Basics of anatomy, physiology
and hormones
Ilan Efraim Gruenwald, Israel
Disorders of male sexual desire 11.15 – 12.00 h
11.15 h
13.30 – 14.00 h
Men's Sexual Function
10.35 – 11.15 h
10.35 h
Sexuality in the elderly population
13.30 h
10.00 – 10.35 h
10.00 h
Sexuality and childhood
Men‘s sexual function
12.00 – 12.20 h
16.00 h
Questions & Answers from the floor
Retrograde and painful ejaculation
Natalio Cruz, Spain
42
Scientific Program
Part III
ABC Master Course
Part IV
09.00 –12.40 h
Yellow Room
13.30 –16.45 h
Erectile dysfunction
09.00 h
09.00 – 10.15 h
09.30 h
First line therapy, second line therapy and
third line therapy
10.00 h
Sexual rehabilitation after pelvic surgery
René Kropman, Netherlands
Testicular disorders
Hormonal disorders and
male sexual dysfunction
10.15 – 10.35 h
Classification, prevalence and predictors
Natalio Cruz, Spain
10.50 h
Nonsurgical approach for PD
Yoram Vardi, Israel
11.10 h
Micropenis, penile involvement in
skin diseases, penile cancer
14.00 h
Hypogonadism
(classification, diagnosis, treatment)
14.20 – 14.45 h
14.20 h
Priapism
a) Classification
c) Medical approach
d) Surgical approach
Mustafa Faruk Usta, Turkey
14.35 h
Penile trauma and facture
a) Classification
c) Surgical approach
Natalio Cruz, Spain
14.45 – 15.00 h
Small penile hematoma
Mondor’s syndrome
Other minor penile disorders
11.40 – 12.20 h
Prostate diseases and sexual function
Micropenis and small penis syndrome
(penile enlargement surgery)
Penile involvement in skin diseases
Penile cancer
(classification, diagnosis, treatment)
Hypospadia / epispadia /
urethral stricture (overview)
Prolactinemia / other hormonal disorders
influencing male sexual functions
Other penile disorders
Surgical approach
Juan Ignacio Martínez Salamanca, Spain
13.50 – 14.20 h
13.50 h
Andrological emergencies
10.35 – 11.40 h
10.35 h
13.30 – 13.50 h
Non-neoplastic testicular diseases
Testicular trauma / acute scrotum
Testicular cancer
Phimosis and short frenulum
Congenital penile curvature
a) Classification
Peyronie‘s disease (PD) and acquired
penile curvature
Yellow Room
Definition, prevalence and predictors
a) Risk factors
b) Diabetes mellitus
c) Cardiovascular disorders
d) Metabolic syndrome
e) Depression
f) Pelvic surgery
Ferdinando Fusco, Italy
Penile disorders
ABC Master Course
15.00 – 15.20 h
Prostatitis
BPH and LUTS
Cobi Reisman, The Netherlands
Cancer and sexuality
Prostate cancer
Bladder cancer
Rectum / colon cancer
Alberto Briganti, Italy
12.20 – 12.40 h
43
15.20 – 15.45 h
Scientific Program
Part IV
ABC Master Course
13.30 –16.45 h
Part V
Yellow Room
09.00 –12.20 h
Genital pain and chronic pelvic pain
René Kropman, The Netherlands
ABC Master Course
Yellow Room
Women's Sexual Function
Anatomy and physiology of
female sexual organs
15.45 – 16.00 h
09.00 – 10.00 h
09.00 h
Anatomy and physiology of the female reproductive system
09.20 h
Neurophysiology
09.30 h
Vascular physiology and relation to
medical conditions
a) Diabetes mellitus
b) Cardiovascular conditions
c) Metabolic syndrome
Male contraception
OAC
Spiral
09.45 h
HPG axis (menstrual cycle and menopause)
Psychological treatment –
When male patient should
receive a psychological counselling?
10.00 h
Hypoactive sexual desire disorders Sexual aversion disorder
b) Risk factors
10.30 h
Psychological treatment
10.45 h
Sexual arousal disorders
b) Risk factors
Sexually transmitted diseases (STDs),
venereal diseases and AIDS
16.00 – 16.20 h
Common STDs (HPV, Herpes, Chlamydia, Gardnerella,
Ureaplasma and Mycoplasma)
The typical venereal diseases (Gonorrhea, Lues, etc.)
Hepatitis
HIV and AIDS
Cobi Reisman, The Netherlands
Contraception and male sexuality
16.20 – 16.30 h
Women‘s sexual dysfunction
16.30 – 16.45 h
44
10.00 – 12.20 h
Scientific Program
Part V
ABC Master Course
09.00 –12.20 h
Part VI
Yellow Room
ABC Master Course
13.30 –15.15 h
Yellow Room
11.05 h
Pelvic floor disorders, urinary incontinence
and female sexual dysfunction
13.30 – 14.00 h
Lior Lowenstein, Israel
Persistent genital arousal disorder
(restless genital syndrome)
a) Classification
c) Risk factors
d) Medical treatments
Marcel D. Waldinger, The Netherlands
11.20 h
Orgasmic disorders
a) Classification
c) Risk factors
d) Medical treatments
11.35 h
Sexual pain disorders / dyspareunia / vaginismus / VVS
a) Classification
c) Medical treatments
d) Surgical approach
12.05 h
Decline in female sexual function
in midlife
14.00 – 14.30 h
Menopause and HRT
a) Classification
b) Medical treatments
d) Psychological treatments
Alessandra Graziottin, Italy
Female external genitals disorder
14.30 – 14.45 h
Enlarged labia / Dismorphic syndrome
Psychological treatment –
When female patient should
receive a psychological counselling?
e) Psychological treatments
45
14.45 – 15.15 h
Poster Presentations
PO-01
Posters
PO-01-010
The effects of new herbal formula (KBMSI-2) on penile erection and expression of
nitric oxide synthase isoforms in streptozotocin-induced diabetic rat model
Byung Il Yoon, Republic of Korea
W. J. Bae, S. J. Kim, S. W. Kim, U. S. Ha
PO-01-011
Natural pigment extracted from mulberry
fruit containing cyanidin-3-O-ß-d-glucopyranoside has a potency to protect erectile
function by minimizing oxidative stress in a
Rat model of diabetic erectile dysfunction
Woong Jin Bae, Republic of Korea
S. J. Kim, T. Y. Ahn, Y. S. Choi, H. J. Cho, S.
PO-01-012
The effects of oral treatment of L-Citrulline
on erectile function in castrated rats
Yuji Hotta, Japan
T. Kataoka, A. Shiota, M. Ohno, Y. Maeda,
M. Morita, T. Hara, K. Kimura
PO-01-013
Hypogonadism and penile arterial disease
are additively associated with increased
aortic stiffness and carotid intima media
thickness
C. Vlachopoulos, K. Rokkas, D. TerentesPrintzios, A. Samentzas, A. Synodinos, M.
Ab
delrasoul, K. Aznaouridis, T. Askitis, C.
Stefanadis
PO-01-014
The prostate after anabolic androgenic steroids. A morphometrical study in rats
Francisco Sampaio, Brazil
R. Vargas, L. Oliveira, S. Frankenfeld, D. de
Souza, W. Costa, L. Favorito
PO-01-015
Effect of the ethanol on the erectile function in the rat
Jae Seog Hyun, Republic of Korea
S. Kam, K. H. Moon
PO-01-016
A comparison between radiotelemetric assessment of intracavernosal pressure and
intraspongiosal pressure for evaluating
apomorphine-induced erection in rats
Jun Ho Lee, Republic of Korea
S. W. Lee, M. Ko, M. R. Chae, S. C. Kam,
J. K. Park, J. H. Jeon, I. So
Basic science
PO-01-001
Clitoral and vaginal blood flows are similarly
reduced in old spontaneously hypertensive
rats and old Wistar-Kyoto rats
A. Salonia, F. Montorsi, P. Rigatti, P. Hedlund
PO-01-003
The effect of oxytocin on the relaxation response in isolated rat vaginal tissue
Hyun-Suk Lee, Republic of Korea
Z. Li, S.-O. Kim, M. Lee, S. I. Jung, K. Park,
J. K. Park
PO-01-005
Genomic, structural and functional expression of a distinct set of chemokine-receptors may be responsible for homing of adipose tissue-derived stem cells towards the
major pelvic ganglion following cavernous
nerve injury
P. Dekoninck, J. Berkers, C. Van Haute, S.
Zia, J. Deprest, D. De Ridder, F. van der Aa
PO-01-006
Nitrergic innervation of vasa nervorum supplying the major pelvic ganglion
Selim Cellek, United Kingdom
S. Smith, N. Cameron, M. Cotter, A. Muneer
PO-01-007
The effects of chard extract on accumulation
of penile free oxygen radicals in streptozotocin-induced diabetes
Mustafa Aydin, Turkey
M. Kadihasanoglu, L. Kabasakal, Y. Ipci, Ö.
Saçan, R. Yanardag, G. Sener, M. Kendirci
PO-01-008
PO-01-009
Oxidative stress-induced alterations in human diabetic cavernosal tissue
Angela Castela, Portugal
R. Soares, P. Van Antwerpen, K. Zouaoui Boudjeltia, T. Roumeguere, P. Gomes,
P. Vendeira, R. Virag, C. Costa
Protective effect of Cyanidin-3-O-ß-d-glucopyranoside concentration materials from
mulberry fruit pigment against oxidative
damage in Streptozotocin-induced diabetic
rat bladder
Yong Sun Choi, Republic of Korea
S. J. Kim, T. Y. Ahn, W. J. Bae, H. J. Cho, S.
46
The effects of the combined use of a phosphodiesterase – 5 inhibitor and medications for hypertension, lower urinary tract
symptoms and dyslipidemia on corporal
tissue tone
Jun Ho Lee, Republic of Korea
M. R. Chae, J. K. Park, J. H. Jeon, S. W. Lee
PO-02-003
Sexuality in men operated for prostate cancer
Birgitte Schantz Laursen, Denmark
PO-02-004
Hypersexuality in Parkinson’s disease: Is
the patient really hypersexual
Gila Bronner, Israel
S. Hassin-Baer
PO-01-018 High blood pressure accelerates penile
arterial insufficiency in young erectile dysfunction patients. A window of opportunity
for preventing vascular disease
C. Vlachopoulos, N. Ioakeimidis, A. Samentzas, D. Terentes-Printzios, A. Synodinos,
A. Aggelis, K. Aznaouridis, T. Askitis, C. Stefanadis
PO-02-005
Clinical management of compulsive sexual
behaviour
Ben Hughes, Ireland
PO-02-006
Gepirone-ER: A potential treatment for depression and sexual dysfunction
Louis F. Fabre, USA
L. C. Smith
PO-02-007
Shared psychotic disorder with sexual delusions – clinical challenge for sexual medicine practitioner
Michal Lew-Starowicz, Poland
PO-02-008
Comprehensive sexological care after spinal cord injury
Tatana Sramkova, Czech Republic
R. Fajtová
PO-02-009
Reclassifying the restless genital disorder
as a sub-type of vulvodynia
Atef Markos, United Kingdom
A. R. Markos
PO-02-010
Criminal consequences of extreme sexual
practices between consenting adults in
Europe
Watcharaphol Kamnerdsiri, France
PO-02-011
The effects of army faboo on soldiers’ sexuality: Facts and consequences
Watcharaphol Kamnerdsiri, France
PO-02-012
Which level of sexual scripts affect on sexual health in couples?
Tayebe Ziaei, Islamic Republic of Iran
F. Ziaei
PO-02-013
When the spice of sex life is missing –
a qualitative study of couples experience of
sex life change in erectile dysfunction as a
result of operation
Anette Højer Mikkelsen, Denmark
PO-01-017
PO-01-019
PO-01-020
Effects of chronic stress on penile corpus
cavernosum of rats
D. De Souza, D. Silva, C. Cortez, W. Costa
Avanafil, a highly selective phosphodiesterase type 5 inhibitor for the treatment of
erectile dysfunction: Selectivity for eleven
PDE isozymes, in comparison with sildenafil, tadalafil, and vardenafil
Run Wang, USA
A. Burnett, K. Omori, J. Kotera, K. Kikkawa,
S. Yee, K. DiDonato, W. Day
PO-01-021 The neurobiology of sexual orientation – the gay brain
Jerome Goldstein, USA
PO-01-022
PO-02
Reproductive function in adult rats submitted to testicular torsion before and during
puberty
R. Milhomem, C. Ribeiro, J. Medeiros JR.,
D. de Souza, M. Pereira-Sampaio
Posters
Psychosexual issues and management
PO-02-001
Our way to approach sexual patients
Ida Bianchessi, Italy
E. Orlando
PO-02-002
Management of sexuality of patients with
cancer and stoma
Ida Bianchessi, Italy
E. Orlando
47
PO-02-014 An internet-based study describing the
psycho-sexual characteristics of subjects
specifically aroused by people with disabilities
Erika Limoncin, Italy
R. Carta, G. L. Gravina, E. Carosa, G. Ciocca,
A. M. Isidori, A. Lenzi, E. A. Jannini
PO-02-015
Adolescencts‘ sexual behavior in Hungary–
do we make enough for them?
Erika Eros, Hungary
PO-02-016 Association of sexual dysfunction with
mental health disorders in a sample of
Greek medical students
Panagiota Anyfanti, Greece
E. Gavriilaki, A. Triantafyllou, P.-A. Avagianou, G. Triantafyllou, B. Nikolaidou, C.
Sachpekidis, N. Lazaridis, N. Papadopoulos,
C. Panagos, M. Doumas (presenter)
PO-02-017
Effects of medications on sexual functioning in patients treated in a day hospital
setting
Goran Arbanas, Croatia
E. Ivezic, S. Maroevic, L. Muzinic
PO-02-018
The power of one session in the treatment
of intravaginal anejaculation
Pierre Assalian, Canada
PO-02-019
Disorders of sexual desire impact your own
quality of life. What about your partner’s?
Mylene Bolmont, Switzerland
G. Lorenz, F. Bianchi-Demicheli, S. Ortigue
PO-03
PO-03-002
Prevalence and potential contributors of
erectile dysfunction among medical students
Eleni Gavriilaki, Greece
P. Anyfanti, A. Triantafyllou, G. Triantafyllou,
K. Petidis, N. Papadopoulos, N. Lazaridis,
C. Panagos, B. Nikolaidou, C. Sachpekidis,
M. Doumas (presenter)
PO-03-003
Erectile dysfunction and diabetes: Results
in a prospective study in Oran (Algeria)
Mohammed Arrar, Algeria
M. Gorine
PO-03-006
The global online sexuality survey – Arabic
version
Osama Shaeer, Egypt
PO-03-007
Is self report of erectile dysfunction associated with severity, cardiovascular risk factors and depression?
Hyun Jun Park, Republic of Korea
N. C. Park, K. Min, S. H. Woo
PO-03-008 Prevalence of metabolic syndrome and
other cardiovascular risk factors in a population of patients with erectile dysfunction
Luis Pacheco-Figueiredo, Portugal
E. Neves, P. Coutinho, F. Botelho, I. Tomada,
N. Tomada
PO-03-009
Traditional cardiovascular risk factors as
potential contributors to sexual dysfunction in male rheumatologic patients
A. Triantafyllou, P. Anyfanti, P.-A. Avagianou,
G. Triantafyllou, A. Pyrpasopoulou, S. Chatzimichailidou, E. Christaki, S. Douma, S. Aslanidis, M. Doumas (presenter)
PO-03-010
Penile angina (PA) concept: The true, the
false and the useful
Posters
ED epidemiology and risk factors
PO-03-001
Help-seeking interval in erectile dysfunction: Analysis of attitudes, beliefs and factors affecting treatment-seeking interval
in Turkish men with previously-untreated
Ömer Gülpinar, Turkey
A. H. Haliloglu, M. I. Abdulmajed, M. S.
Boga, O. Yaman
PO-03-011 Is serum hsCRP associated with erectile dysfunction in aging men? Community
based study
Won Ki Lee, Republic of Korea
S. K. Lee, D. H. Kim, D. G. Moon, J. J. Kim,
S.-C. Kim, D. Y. Yang, S.-K. Yang
48
PO-03-012
Evaluating erectile dysfunction in patients
attending a rheumatology department:
A pilot study
Areti Triantafyllou, Greece
E. Gavriilaki, P. Anyfanti, G. Triantafyllou,
A. Pyrpasopoulou, S. Chatzimichailidou, E.
Gkaliagkousi, N. Papadopoulos, S. Douma,
S. Aslanidis, M. Doumas
PO-04-004
The effect of erectile dysfunction on global health-related quality of life in patients
with rheumatic diseases
P. Anyfanti, E. Gavriilaki, P.-A. Avagianou,
G. Triantafyllou, A. Pyrpasopoulou, S. Chatzimichailidou, E. Gkaliagkousi, S. Douma,
S. Aslanidis, M. Doumas
PO-03-013
Management of penil fracture, effects on
erectile function: Conservative treatment
or early surgical treatment
Alper Ozorak, Turkey
M. B. Hoscan, T. Oksay, A. Kosar, A. Guzel
PO-04-005
PO-03-014
Coronary and pelvic arteries CTscan in patients with vasculogenic ED free of cardiac
symptoms
J. F. Paul
The impact of erectile dysfunction on sexual-specific quality of life in patients with
rheumatic disorders
Giorgos Triantafyllou, Greece
E. Gavriilaki, A. Triantafyllou, P. Anyfanti,
P.-A. Avagianou, A. Pyrpasopoulou, S. Chatzimichailidou, K. Petidis, S. Douma, S. Aslanidis, M. Doumas (presenter)
PO-04-006
Testosterone and cardiovascular risk in patients with erectile dysfunction
G. Rastrelli, G. Balercia, G. Forti, E. Mannucci, M. Maggi
PO-04-007
Correlation between NIH category IV prostatitis and erectile dysfunction
Alper Ozorak, Turkey
T. Oksay, E. Capar, A. Kosar, M. B. Hoscan
PO-04-008
Sexual function in azoospermic and oligospermic men
Sotirios Koukos, Greece
S. Vappa, D. Baltogiannis, D. Giannakis,
P. Tsounapi, A. Takenaka, E. Vlachopoulou,
N. Kolitsas, N. Sofikitis, F. Dimitriadis
PO-04-009
A pilot study to evaluate the effects of vardenafil on sexual distress in men with obesity
M. Natali, D. Francomano, R. Bruzziches,
A. Guerra, M. Latini, L. M. Donini, A. Lenzi
PO-03-015
PO-04
The involvement of prostate cancer therapy
in couple life: Open, laparoscopic, robotic
and HIFU approach
Cristian Nicolae Manea, Romania
I. Hiriscau, R. Maxim, N. Crisan, F. Dobrota,
I. Coman
Posters
ED and co-morbidities
PO-04-001
PO-04-002
PO-04-003
Sexual dysfunction and quality of life in
female and male patients with myocardial
infarction
Zeynep Özer, Turkey
H. Bektas, F. Arıkan, N. Vicdan
High serum uric acid level is associated
with penile vascular disease severity and
increased aortic stiffness in erectile dysfunction patients with metabolic syndrome
C. Vlachopoulos, N. Ioakeimidis, A. Aggelis, D. Terentes-Printzios, A. Synodinos,
A. Samentzas, E. Christoforatou, T. Askitis,
C. Stefanadis
PO-05
Posters
Male sexual health (aging male, hormones, lifestyle
factors)
PO-05-001
Sexual life of men after coronary artery bypass graft surgery
Violetta Skrzypulec-Plinta, Poland
J. Wanot, A. Skrzypulec
49
Stable extramarital affairs are breaking the
heart
Alessandra Daphne Fisher, Italy
E. Bandini, G. Corona, M. Monami, M. Cameron Smith, C. Melani, D. Balzi, G. Forti,
E. Mannucci, M. Maggi
PO-05-002
Varicocele and male aging: Results of a
controlled study
Giuseppe Maio, Italy
PO-05-004
Dysaesthetic Penoscrotodynia: The male
equivalent of Vulvodynia
Atef Markos, United Kingdom
PO-05-005
PO-05-006
A study of the attitudes and behaviors of
Korean men to complementary and alternative medicine for the improvement of
sexual function: The Korean Internet Sexuality Survey (KISS), part II
Sang Hoon Song, Republic of Korea
W. S. Choi, H. Son (presenter), J.-S. Paick
PO-05-012
Long acting testosterone undecanoate improved diabetes control versus placebo in a
hypogonadal population with type 2 diabetes
G. Hackett
PO-05-013
Analysing by decade, testosterone undecanoat depot injectable does not increases
prostate volume. Study on 140 hypogonadic patients without prostatic cancer
Dan Peretianu, Romania
M. Carsote, C. Poiana, D. C. Staicu
PO-05-014 Testosterone undecanoat 1000 mg at
3 months does not increase PSA level
after 1 year. Study on 70 patients
Dan Peretianu, Romania
M. Carsote, C. Poiana, D. C. Staicu
Hypogonadism as a risk factor for cardiovascular mortality in men: A meta-analytic
study
G. Corona, M. Monami, A. Guay, J. Buvat,
A. Sforza, G. Forti, E. Mannucci, M. Maggi
PO-05-015
Increases in bone mineral density and lean
body mass in men with late onset hypogonadism upon 12 months of treatment
with 50 mg testosterone gel followed by
12 months testosterone undecanoate
Josep Rodriguez Tolra, Spain
J. M. Cuadrado Campaña, J. Torremadé
Barreda, E. Llorens de Knecht, E. Franco
Miranda
PO-05-016
Effects on cardiovascular risks and safety of
12 months of treatment with 50 mg testosterone gel followed by 12 months testosterone undecanoate in men with late onset
hypogonadism
Josep Rodriguez Tolra, Spain
J. M. Cuadrado Campaña, J. Torremadé
Barreda, E. Llorens de Knecht, E. Franco
Miranda
PO-05-007 Hypogonadotropic Hypogonadism: Changes in testicular blood flow and appearance
after treatment with gonadotrophins
Khaleeq Ur Rehman, Pakistan
K. Shahid, H. Humayun
PO-05-008
Low total testosterone concentration and
increased CRP levels are associated with
decreased exercise capacity in essential
hypertensive men
N. Ioakeimidis, D. Terentes-Printzios, A. Ag
gelis, A. Synodinos, A. Samentzas, E. Christoforatou, K. Rokkas, T. Askitis, C. Stefanadis
PO-05-009
Results of CO-SDT study: Prevalence and
risk factors of metabolic syndrome in a
population of 2508 men with testosterone
deficiency syndrome
Eduardo García-Cruz, Spain
Ó. Cardeñosa, P. Luque, A. Alcaraz
PO-05-010
Testosterone deficiency in males: Prevalence
and relation with metabolic parameters
Antonio Becerra, Spain
M. Menacho, G. Perez-Lopez, M. J. Lucio,
N. Asenjo, J. M. Rodriguez-Molina, J. M. Del
Rey
PO-05-011
Prevalence of LOH in Korea: A nationwide
study
Du Geon Moon, Republic of Korea
S. W. Lee, J. K. Park, K. S. Park, H. S. Ahn,
K. A. Male Study Group
PO-05-017 Time-course of effects of testosterone
treatment: From beginning to maximum
therapeutic effect
Farid Saad, Germany
A. Aversa, A. Isidori, M. Zitzmann, L. Gooren
PO-05-018
50
The influence of lower urinary tract symptoms during testosterone replacement therapy in men with testosterone deficiency
syndrome
Hong Seok Shin, Republic of Korea
J. S. Park, K. H. Moon, P. H. Song
PO-05-019
Varicocelectomy in middle-aged patients
with erectile dysfunction: Serum testosterone and sexual function modifications
Giuseppe Maio, Italy
G. Maio, S. Saraeb
PO-05-020
Sex: The new healthcare inequality
Odunayo Kalejaiye, United Kingdom
R. Pearcy
PO-05-021
Safety of testosterone replacement for hypogonadism associated with sickle cell disease: A pilot report
Belinda Morrison, Jamaica
M. Reid, W. Madden, A. Burnett
PO-05-022
Barriers to knowledge, awareness and diag
nosis of erectile dysfunction and low testosterone in men: Survey of 1019 men and
222 general practitioners in the UK
L. E. Kember
PO-06
PO-07
ED medical treatment
Posters
PO-07-001
Safety and efficacy of Tadalafil 5 mg administered once daily in men with erectile dysfunction and lower urinary tract symptoms
Tai Young Ahn, Republic of Korea
S. Hong
PO-07-002
Effects of daily PDE5 inhibitors on endothelial function in men with vascular ED:
Results from a preliminary randomized,
double-blind, placebo-controlled spontaneous study
D. Francomano, R. Bruzziches, A. Lenzi
PO-07-003
The use of a combination of a long- and
short term PDE-5-Inhibitor in patients with
severe ED: Results from an open-label uncontrolled study
H. Van Poppel
PO-07-004
Vardenafil on demand improves endothelial dysfunction and vascular inflammation markers
R. Mansani, G. de Vita, G. Forti, M. Maggi
PO-07-005
Effect of daily tadalafil and monthly testosterone enanthate on PDE5-inhibitor nonresponders
Jinwook Kim, Republic of Korea
B. K. Ham, D. Y. Yang, J. J. Kim, D. G. Moon,
M. M. Oh, C. H. Lee, M. Park
PO-07-006
Improvement in sexual quality of life of the
female partner following vardenafil treatment of men with erectile dysfunction:
A randomised, double-blind, placebo-controlled study
Antonio Martín-Morales, Spain
A. Graziottin, G. Bou Jaoudé, F. Debruyne,
J. Buvat, M. Beneke, D. Neuser
PO-07-007
Efficacy and safety of Tadalafil (Cialis) in
men with erectile dysfunction secondary
to radical prostatectomy or hormone-radiotherapy in patients with prostate cancer
Abdallah Mashal, Israel
W. Mermershtain
ED diagnosis
PO-06-001
PO-06-002
Serum levels of asymmetric dimethylarginine and testosterone among Egyptian type
2 diabetic men with erectile dysfunction as
risk markers for coronary artery disease
Khaled Gadalla, Egypt
A. Abdel Fattah, H. Kandeel, A. Ali
Is erection hardness score questionnaire a
valid tool to evaluate penile rigidity?
Luigi Gallo, Italy
R. Giannella, S. Pecoraro
PO-06-003
Serum C-reactive protein levels and response rate to tadalafil 5 mg once daily in
erectile dysfunction patients with diabetes
Hyun Jun Park, Republic of Korea
N. C. Park, K. Min, S. H. Woo
PO-06-004
Is blood viscosity related with other diag
nostic tools in the patients with erectile
dysfunction?
Kwangsung Park, Republic of Korea
C. Zhao, J. K. Park
Posters
51
PO-07-008
Treatment of erectile dysfunction with phosphodiesterase type 5 inhibitor (PDE5 INH)
in male partner of women with vaginismus
Hamdi Ozkara, Turkey
E. Akkus, S. Dinc, B. Alici, B. Tek
PO-07-018Viberect® device use by men with erectile
dysfunction: Safety, ease of use, tolerability
and satisfaction survey
Kambiz Tajkarimi, USA
A. L. Burnett
PO-07-009
Phase III clinical trial of avanafil in the
treatment of erectile dysfunction
Jong Kwan Park, Republic of Korea
K. Park, S. W. Kim, J. J. Kim, N. C. Park,
S. W. Lee, J. S. Paick, T. Y. Ahn, J.-K. Suh,
W. S. Chung
PO-07-019
PO-07-010
Efficacy and safety of vardenafil for the
treatment of erectile dysfunction in men
with metabolic syndrome: Results of a randomised, placebo-controlled trial
Tim Schneider, Germany
J. Gleißner, F. Merfort, M. Hermanns, M. Beneke, E. Ulbrich
PO-07-020 Satisfaction evaluation of patients under intracavernous injection treatment for
Asterios Fotas, Greece
S. Hintzoglou, C. Sidiropoulos, S. Charalambous, A. Papathanasiou, G. Salpingidis
PO-07-011
Can dose fragmentation of Tadalafil 10 or
20 mg efficiently reduce the incidence of
headache as adverse event?
George Mitroi, Romania
S. Dena, C. Nedelcuta, A. Drocas
PO-07-012
Doc, are viagra and friends risky? patients’
attitude about pde5is information leaflet in
the web-networking generation?
D. Moretti, A. Saccà, F. Abdollah, F. Castiglione, M. C. Clementi, G. Castagna, U. Capitanio, P. Rigatti, F. Montorsi
PO-07-013
Is trigger androgen therapy effective in metabolic syndrome?
Vladimir Naskhletashvili, Russia
Y. Yesilevsky
PO-07-014
The effect of herbal combination formula
HM on male sexual function and satisfaction: A placebo-controlled, double blind
clinical study
E. Hattat, I. Hattat
PO-07-015
PO-07-016
PO-07-021
PO-08
Distribution of therapeutic concepts for rehabilitation of erectile function after nervesparing radical prostatectomy in Germany
Andreas Bannowsky, Germany
A. Raileanu, A. Müller, R. Ataniyazov, H. van
Ahlen
Conservative treatment of mild and moderate vasculogeic erectile dysfunction
Romaniuk Maksym, Ukraine
A. Kornienko, A. Gurzhenko
Posters
ED surgical treatment
PO-08-002
Intraoperative penile modelling for acquired curvature before inflatable prosthesis
insertion: First case
Edoardo Pescatori, Italy
B. Drei
PO-08-003 Three-pieces penile prosthesis with SIS
patch perforation and SST deformity: Correction by autologous rectus fascia graft
and distal corpus cavernosum incision by
urethrotome
Edoardo Pescatori, Italy
B. Drei, P. Pisi
Herbal treatment for erectile dysfunction:
A review of current evidence
Christopher C. K. Ho, Malaysia
H. M. Tan
The experience of the modern homeopathic treatment of sexual disorders in men
I. Gurzhenko, R. Maksym, A. Boiko, A. Kornienko
52
PO-08-005
The albuginea plication for the recurvatum penis secondary in Peyronie’s disease
(IPP): A traditional surgical procedure
Giandomenico Passavanti, Italy
A. Bragaglia, R. Nucciotti, E. Spinosa, M.
Gnech, V. Pizzuti
PO-08-006
Management of unsuspected Peyronie’s disease among Egyptian population
Khaled Gadalla, Egypt
PO-08-007
Effect of PDE5 inhibitor in nonsurgical
management of Peyronie’s disease: Preliminary study
Byeong Kuk Ham, Republic of Korea
J. w. Kim, M. Oh, D. y. Yang, J. Kim, D. Moon
PO-08-008
Ultrasonographic comparison of tunica albuginea substitutes for the treatment of
peyronie´s disease
Artur Palmas, Portugal
M. Ferreira Coelho, P. Cardoso, J. Fonseca
PO-08-009
PO-08-010
PO-08-011
PO-09
Sexual function preservation with the prostatic urethral lift, a minimally invasive
therapy for lower urinary tract symptoms
secondary to BPH
E. Laborde, H. Woo, D. Bolton, P. Chin, G.
Jack, P. Rashid, J. Thavaseelan, K. McVary
PO-09-002
Super-selective metachronous embolization of post traumatic bilateral arterio-cavernosal fistula: Case report
Franco Gadda, Italy
M. G. Spinelli, G. Cozzi, A. Nicolini, G. Garaffa, M. P. Serrago, P. Acquati, P. Dell´Orto,
F. Rocco
PO-09-004
Correlation of proximal and distal corpus
cavernosum biopsy with colour doppler ultrasonography in ischaemic priapism
A. Skolarikos, A. Muneer, A. Freeman, A. Papatsoris, S. Minhas, C. Deliveliotis, D. Ralph
PO-09-005 Penile prosthesis implantation in treatment of erectile dysfunction after priapism
in sickle cell disease
Isabelle Souillac, France
D. Bachir, O. Sibaud, R. Virag
Treatment outcomes of erectile dysfunction following radical prostatectomy
Milos Brodak, Czech Republic
P. Navratil, J. Kosina, M. Louda, L. Holub,
J. Pacovsky
PO-10
Posters
Penile reconstructive surgery
PO-10-001 Sexual life and patient satisfaction following penis-sparing surgery for benign,
premalignant or malignant penile lesions
F. Fusco, E. Berdondini, S. Maruccia, A. Salonia, G. Zuccati
Daily administration of low dose PDE5inhibitor in patients underwent bilateral nerve sparing radical prostatectomy:
Evaluation of erectile function
Asterios Fotas, Greece
V. Sakalis, D. Alexandridis, A. Triantafyllidis,
A. Papathanasiou, G. Salpingidis
PO-10-002 Epithelioid sarcoma of the penis mimicking Peyronie’s disease. A case report
Alessandro Franceschelli, Italy
G. Passaretti, B. Barbieri, F. Colombo
Posters
Priapism
PO-09-001
PO-09-003
Testosterone deficiency is a possible risk
factor for priapism associated with sickle
cell disease
Belinda Morrison, Jamaica
M. Reid, W. Madden, Z. Feng, A. Burnett
89 cases of priapism: What changes after
an experience of 25 years?
I. Jallouli, F. Ozone, A. Demey
53
PO-10-003
Penile augmentation surgery by micronized
human dermal tissues
PO-10-004
External genitalia avulsed plagues-rare conditions demanding special management
George Mitroi, Romania
H. Parvanescu, S. Dena, C. Nedelcuta, A.
Drocas
PO-10-005
The utility of “collagen matrix” in penile
andrological surgery
Riccardo Vaccari, Italy
F. Pezzoni
PO-10-006
PO-11
Tolerability and efficacy of newly developed
penile injection of cross-linked dextran and
polymethylmethacrylate mixture on penile
enhancement: 6-months follow-up
Won Ki Lee, Republic of Korea
J. J. Kim, D. G. Moon, D. Y. Yang, S.-C. Kim
Posters
PO-11-007
Improving ejaculatory or orgasmic dysfunction after 12 wks as-needed tadalafil treatment significantly improves intercourse
and overall sexual satisfaction in men with
erectile dysfunction: Post-hoc analyses of
17 placebo-controlled studies
Darius Paduch, USA
PO-11-008
66% of men with severe ejaculatory or
orgasmic dysfunction report improved ejaculatory or orgasmic function after 12 wks
as-needed tadalafil treatment: Post-hoc
analyses of 17 placebo-controlled studies
Darius Paduch, USA
PO-11-009
The impact of Visual Internal Urethrotomy
(VIU) on sexual function
Ki Hak Moon, Republic of Korea
P. H. Song, H. S. Shin, J. S. Hyun
P0-11-010
Awareness of premature ejaculation (PE) in
Austria: Analyses of >5000 internet based
data
Raphael Müller, Austria
G.M. Pinggera, W. Harninger, A. Jungwitth
Ejaculatory disorders
PO-11-001
PO-11-002
PO-11-003
PO-11-004
PO-11-005
PO-11-006
Validity of the premature ejaculation diag
nostic tool (PEDT) in four subgroups of
premature ejaculation syndrome: Data
from the Korean Internet Sexuality Survey– part I
Sang Hoon Song, Republic of Korea
W. S. Choi, H. Son (presenter), J.-S. Paick
Patients affected by premature ejaculation
due glans hypersensitivity refuse circumcision as potential definitive treatment for
their problem
Luigi Gallo, Italy
R. Giannella, S. Pecoraro
Evaluation of correlation between premature ejaculation and frequency of sexual
intercourse
Su-Yeon Jang, Republic of Korea
PO-12
Posters
Homosexuality and gender identity disorders
The prevalence of premature ejaculation
and clinical characteristics of Korean men
as according to different definitions
Sung Won Lee, Republic of Korea
J. H. Lee, H. J. Park, J. K. Park, S. Choi,
S. C. Kam
PDE 5 Inhibitor and SSRI vs. SSRI only in
the treatment of premature ejaculation
Emre Akkus, Turkey
H. Ozkara, B. Alici, C. Dogan
Clinical efficacy of paroxetine in the treatment of patients with premature ejaculation
caused by chronic nonspecific prostatitis
Y. Gurzhenko, A. Gurzhenko, R. Maksym
54
PO-12-001
Childhood maltreatment in subjects with
male to female gender identity disorder
Elisa Bandini, Italy
A. D. Fisher, V. Ricca, M. C. Meriggiola, E. A.
Jannini, C. Manieri, G. Corona, J. Ristori, E.
Fanni, M. Maggi
PO-12-002
Long-time effects on ferritin and other components of metabolic syndrome of the crosssex hormone-treatment in transsexuals
Antonio Becerra, Spain
G. Perez-Lopez, M. Miriam, J. M. Del Rey,
M. J. Lucio, N. Asenjo, J. M. RodriguezMolina
PO-12-003
Reproductive wish in female-to-male transsexual persons
Katrien Wierckx, Belgium
E. Van Caenegem, E. Elaut, P. de Sutter,
G. T´Sjoen
PO-12-004
Comparisons and synergies of the different
professional competences in the sex reassignment surgery
Paola Mutinelli, Italy
D. A. Nadalin, A. P. Sanfelici, P. Stella, A.
Franceschelli, F. Colombo
PO-12-005
Review of published Arabic writings on homosexuality and lesbianism in Arab societies
Mohamed Mahgoub, Egypt
M. Mahgoub
PO-13
PO-13-006 Estimating prevalence and predictors of
sexual dysfunction among female medical
students
Giorgos Triantafyllou, Greece
A. Triantafyllou, E. Gavriilaki, P. Anyfanti,
K. Petidis, E. Gkaliagkousi, N. Papadopoulos, E. Christaki, N. Lazaridis, B. Nikolaidou,
M. Doumas (presenter)
PO-13-007
Prevalence of sexual dysfunction among
female patients attending a rheumatology
department
A. Triantafyllou, P. Anyfanti, G. Triantafyllou,
A. Pyrpasopoulou, E. Gkaliagkousi, S. Chatzimichailidou, K. Petidis, S. Douma, S. Aslanidis, M. Doumas (presenter)
PO-13-008
How can sexual self concept preserve sexual
health in Iranian young women?
Tayebe Ziaei, Islamic Republic of Iran
E. Merghati Khoei, M. Salehi, Z. Farajzadegan
PO-13-009
Sexual function relates to dimensions of
the personality in a clinical sample of postmenopausal women
E. Martini, Italy
E. Terreno, E. Brambilla, F. Albani, V. Santamaria, S. Tonani, I. Saletta, E. Martini, E. Terreno, E. Brambilla, F. Albani, V. Santamaria,
S. Tonani, I. Saletta, R. E. Nappi
PO-13-010
The role of traditional cardiovascular risk
factors in sexual functioning of female patients suffering from musculoskeletal disorders
E. Gavriilaki, P. Anyfanti, G. Triantafyllou,
A. Pyrpasopoulou, S. Chatzimichailidou,
E. Gkaliagkousi, K. Petidis, S. Douma, S. Aslanidis, M. Doumas
PO-13-012
Sexual function of partners to women with
pelvic floor dysfunction
Risa AM Lonnee-Hoffmann, Norway
S. Mørkved, Ø. Salvesen, B. Schei
Posters
PO-13-001
Arabic translation of female sexual function index and validation in an Egyptian
population
Tarek Anis, Egypt
S. Aboul Gheit
PO-13-002
Female sexual function in Spain: Normal
range
Fatima Castroviejo Royo, Spain
C. Conde Redonde, J. M. Martinez-Sagarra
Oceja, L. A. Rodriguez Toves, J. F. Sanchez
Garcia
PO-13-003
Female sexual function in Spain: Descriptive analysis
C. Conde Redondo, J. M. Martinez-Sagarra
Oceja, L. A. Rodriguez Toves, A. Rivero Cardenes
PO-13-004
PO-13-005
Female sexual function in Spain: New diag
nostic points female sexual dysfunction in
Castilla y Leon (Spain)
C. Conde Redondo, M. J. Martínez-Sagarra
Oceja, L. A. Rodriguez Toves, J. A. Mainez
Rodríguez
Female sexuality and popular media during
the communist period (1944 – 1989) in
Bulgaria
Rumyana Georgieva, Bulgaria
Z. Kamenov
55
PO-13-013
PO-13-014
PO-13-015
Revaluation of classification of female sexual dysfunctions
O. Romashchenko, S. Melnykov, V. Bilogolovskaya, S. Koval
Perception of body image and sexuality in
women with breast cancer
Birgitte Schantz Laursen, Denmark
H. D. Nielsen, A. M. Gregersen, C. B. Thorup
Preliminary results on the effect of vaginal
estrogen on sexual function in women with
interstitial cystitis painful bladder syndrome (ic / pbs)
Barbara Gardella, Italy
D. Porru, A. Chiesa, V. Musacchi, A. D. Iacobone, F. Albani, A. Spinillo, B. Gardella,
D. Porru, A. Chiesa, V. Musacchi, A. D. Iacobone, F. Albani, A. Spinillo, R. E. Nappi
PO-13-016
Sex, body and cancer: Sexuality and body
image of Brazilian women after breast cancer
Daniela Barsotti Santos, Brazil
M. A. dos Santos, E. M. Vieira
PO-13-017
The influence of danazol on angiogenesis
and inflammatory response in endometriosis
Maria Szubert, Poland
K. Kowalczyk-Amico (presenter)
PO-13-018
PO-13-019
PO-14
PO-14-002
When is an STD not just an STD?
Ben Hughes, Ireland
PO-14-003
Where do patients go for treatment of urethritis?
Mustafa Burak Hoscan, Turkey
A. Tunckiran, T. Oksay, A. Özorak, H. Özkardei
PO-14-004
Microbiological control of azitromycin therapy in sexually transmitted mixed infections
Natalia Tarabrina, Russia
I. Khamaganova, K. Akhmedov, S. Khromova, M. Mezenceva, L. Kovalchuk, L. Gankovskaya, L. Degtyareva, I. Khamaganova
PO-15
Posters
Miscellaneous
PO-15-001
The risk of hypogonadism in cancer survivors with stage-i testicular seminoma treated by adjuvant radiotherapy
Giovanni Luca Gravina, Italy
P. Bonfili, M. Di Staso, E. Carosa, E. Limoncin, G. Ciocca, S. Di Sante, A. Lenzi, L. Gandini, V. Tombolini, E. A. Jannini
PO-15-002 The ROSA experience: Lessons from a
health professional network to reduce the
inequality of access to oncosexological
care
D. Habold, T. Damiano, P. Champsavoir
Type 1 diabetic premenopausal women affected by sexual genital arousal disorder
treated with Tadalafil 5 mg daily
Salvatore Caruso, Italy
C. Agnello, C. Cicero, C. Malandrino, L. Lo
Presti, M. Romano, A. Cianci
PO-15-003 Oncosexology: Assessment and potential
role for the major French patients association LCC (La Ligue Contre le Cancer)
P. Champsavoir, T. Damiano, D. Habold
Satisfaction in overal female sexual life
after vaginal surgery
C. Conde Redondo, J. M. Martínez-Sagarra
Oceja, L. A. Rodríguez Toves, A. Rivero Cardenes
PO-15-004
Oncosexology and health care offer: A specific survey in 285 health carers in order to
specify the perceived needs for information
or training
D. Habold
PO-15-005
Modern treatment of penile cancer: Results
from a supraregional centre
Shaista Ahmed, United Kingdom
N. Rukin, M. Foster
Posters
Sexually transmitted diseases (STD)
PO-14-001 Sexual behavior of patients with gonorrhoea in relation to orientation
Martina Kojanova, Czech Republic
I. Kuklova, P. Velcevsky, J. Belacek
56
PO-15-006
Evaluation of patient’s sexual function before and after renal transplantation
Mohammad Reza Darabi Mahboub, Islamic
Republic of Iran
M. H. Shakibi
PO-15-007
Suicidal behaviour in street prostitutes
Alexandre Teixeira, Portugal
PO-15-008
Sexual motivation: An exploratory study in
a Greek sample
Evangelia Nakopoulou, Greece
S. Papaharitou, A. Macaskill, K. Wylie,
H. Florou, D. Hatzichristou
PO-15-009
Integrating sexology education into psychiatry residency training: Perspectives from
the USA
Dennis Lin, USA
E. Kleinbart
An evaluation of telephone follow up consultation for management of patients with
Uday Joshi, United Kingdom
J. Agius
PO-15-010
PO-15-011
Bisexual identity and psychological distress in a sample of Czech male sex workers
Michael D. Johnson, Czech Republic
PO-15-012
Is the web changing the relationship between the clinicians and the patients with
sexual disorders? Results of an exploratory
analysis
F. Abdollah, A. Saccà, M. Ferrari, F. Castiglione, D. Moretti, G. Castagna, M. C. Clementi, G. Zanni, P. Rigatti, F. Montorsi
PO-15-013
Erectile dysfunction in diabetic men
Mohammad Reza Darabi Mahboub, Islamic
Republic of Iran
R. Taghavi, A. Rezaei Ardani
PO-15-014
Needle electrode coagulation of pronounced
pearly penile papules
Ferenc Fekete, Hungary
57
PO-15-015
Pharmacokinetics of avanafil; a novel, rapidly-absorbed, selective PDE5 inhibitor
for the treatment of mild to severe erectile
dysfunction (ED)
Mark Allison, USA
T. Grant, M. Obaidi, T. Marenco, S. Yee,
W. Day
PO-15-017
Idiopathic partial thrombosis of the Corpus
Cavernosum (IPT) – a case report and review of the literature
Mariam Hulth, Denmark
M. Fode (presenter), R. Bisbjerg, J. Sønksen
(presenter)
PO-15-018
Surgical correction of grade III Gynecomastia and its impact on sexuality
Osama Shaeer, Egypt
PO-15-019
The use of photodynamic therapy (PDT)
in the treatment of penile vascular malformations
Amr Raheem, United Kingdom
D. Ralph, C. Hopper
PO-15-020
The correlation between circumcision and
a decrease in sensitivity of the penis
P. B. Kim
PO-15-021
The influence of the penile constriction
band and the penile circumference of Korean men
P. B. Kim
PO-15-022
Cross cultural analysiys of sexual self-disclousure among couples
Fabrizio Quattrini, Italy
E. Belfiglio
ESSM
European Society for
Sexual Medicine
Benefits from Becoming an
ESSM Member
Take Your Chance –
Become a Member of ESSM, Now !
n ESSM offers its members a permanently updated web-site
with different forums and a monthly update of the whole
scientific literature of Sexual Medicine, Andrology and
related medical disciplines.
Seize the day, or in Latin Carpe diem and become a member of
ESSM now, to take all the advantages and benefits of ESSM
membership.
There are two levels of ESSM membership available:
n ESSM provides its members quarterly newsletter, ESSM
Today which features the most recent news in the field of
Sexual Medicine and focuses on key topics of interest to
physicians in the field. It is intended that the ESSM Today
Newsletter will also be translated into the most important
European languages.
nAt present under the leadership of ESSM a European
Curriculum for Sexual Medicine is being developed together
with other medical disciplines and the Union Européene Des
Médicines Spécialistes (UEMS). This will ultimately lead,
we hope, to an examination in the field of Sexual Medicine
which in turn will lead to a European Qualification for Sexual
Medicine.
n Since 2007 ESSM has offered interested ESSM members
the participation in a two week structured course of the European School of Sexual Medicine. This course is organized
each year in July in Oxford (UK) by John Dean, the ESSM
director for Education.
nBesides this structured course ESSM offers at its annual
congresses both instructional courses related to topics of
interest in Sexual Medicine and Master Courses covering
the key contents of the ESSM educational program.
n ESSM provides to its members both research grants and
fellowship supports, either on individual application and
after approval by the ESSM Scientific Committee.
ESSM /ISSM Membership
A combined ESSM / ISSM membership (annual fee 120 EUR) for
both Sexual Medicine Societies (ESSM /ISSM) including all ESSM
and ISSM membership related services, including a subscription
to the Journal of Sexual Medicine which is the monthly journal of
the ISSM (International) and ESSM (European), and is the leading Journal in the field of Sexual Medicine. In addition there are
reduced registration fees for all ISSM /ESSM related congresses.
ESSM only Membership
ESSM only membership (annual fee 50 EUR) which includes the
ESSM official Scientific and Social periodical, the „ESSM Today“,
full access to the new comprehensive ESSM website:
www.essm.org
(including regularly updated scientific material, monthly updated
literature reviews, the most recent guidelines, lecture recordings
and presentations from past ESSM congresses), the opportunity
to participate in the ESSM educational programs, and to apply for
scientific and support grants and a reduced fee for the ESSM
annual congress.
Formal ESSM membership applications can either be submitted
directly to the ESSM or through one of the national ESSM affiliated societies. The ESSM Executive Committee is responsible for
the approval of the membership application.
ESSM Annual Membership Fees from 2012
European Society for Sexual Medicine
ESSM SECRETARIAT
Daniela Pajola | Via Ripamonti 129 | 20141 Milano, Italy
phone: +39 02 – 56601 625 | fax: +39 02 – 70048 577
email: [email protected]
Combined ESSM /ISSM
Fee incl. JSM Journal
EUR 120
ESSM only Fee
EUR 50
www.essm.org
guests@ESSM
Germano Celant, renowned art historian, critic, and theoretician, has served as the curator of hundreds
of exhibitions worldwide and published more than one hundred books and catalogues.The artistic
director of the fondazione Prada, Milan, since 1995, Celant is also the curator of the fondazione aldo
rossi in Milan, curator of the fondazione Emilio e annabianca Vedova in Venice, and curator of art
and architecture at La Triennale di Milano. he was the senior curator of contemporary art at the Solomon r. guggenheim Museum in new York from 1989 until 2008, the artistic director of the first biennale di firenze (1996) and the curator of the 47th Venice biennale (1997), and artistic supervisor
for genoa’s year as European Cultural Capital in 2004, among many other exhibitions. a longtime
contributing editor to artforum and interview Magazine, Celant writes regular columns for the italian
magazines L'Espresso and interni. he received the frank Jewett Mather award, honoring exceptional
art criticism, in 1987.
Mariangela Mianiti, journalist and writer, was born in Parma and lives between Milan and Switzerland.
She worked for many magazines, newspapers and some radios. in 2003 she won the reporter of the
Year award and in 2005 the prize Maria grazia Cutuli. in 2005 she published Una notte da entraineuse. Lavori, consumi e affetti narrati da una reporter infiltrata and in 2009 La vita Viagra. Uomini, pillole, sesso e relazioni (derive approdi).in 2011 she published her first romance anche il caviale stanca
(Sonzogno). Currently she works with the two magazines Vanity fair and amica.
59
List of Exhibitors – Exhibition Plan
Booth No.
Exhibitors
Exhibitors A – Z
1
ESSM – European Society for Sexual
Medicine
American Medical Systems
10
Bayer HealthCare Pharmaceuticals
5
2
ISSM – International Society for
Sexual Medicine
Coloplast
6
Direx GmbH
8
3A
ESHA – European Sexual Health
Alliance
3B
EFS – European Federation of
Sexology
4
Eli Lilly & Company
5
Bayer HealthCare Pharmaceuticals
6
Coloplast
7
8
10
Booth No.
EFS – European Federation of
Sexology
3B
Eli Lilly & Company
4
ESHA – European Sexual Health
Alliance
3A
ESSM – European Society for Sexual
Medicine
1
ISSM – International Society for
Sexual Medicine
2
Direx GmbH
American Medical Systems
ITAMAR MEDICAL
14
11A
MEDISPEC Ltd.
12
11B
Kessel GmbH
Kessel GmbH
11B
12
MEDISPEC Ltd.
NAMED S.p.A.
13
13
NAMED S.p.A.
Reflexonic
15
14
ITAMAR MEDICAL
7
15
Reflexonic
11A
EXHIBITION FLOOR PLAN, Hall B
Level 1
Session Rooms
Red, Blue Yellow, Speakers Centre
3B 3A
2
1
4
Coffee Area
5
Entrance
14 12
15 13
Snack Bar
60
10
11 11
B A
8
6
7
List of Chairpersons and Presenters
Brody, S. ........................................................... 23, 29, 42
Bronner, G. ............................................................. 28, 47
Brotto, L. A. ............................................................ 37, 41
Bunker, C. .................................................................... 39
Buvat, J. ........................................................... 23, 24, 33
A
Abbona, A...................................................................... 29
Aggelis, A. ..................................................................... 35
Ahmed, S. ..................................................................... 56
Ahn, T. Y. ...................................................................... 51
Akkus, E. ................................................................ 34, 54
Alarie, P. ....................................................................... 23
Albersen, M. ............................................... 26, 28, 36, 46
Allison, M. ..................................................................... 57
Althof, S. ....................................................................... 37
Amar, E. ........................................................................ 39
Angulo, J. ......................................................... 25, 28, 36
Anis, T. ......................................................................... 55
Anyfanti, P. ............................................................. 38, 48
Arbanas, G. ................................................................... 48
Arnaud-Beauchamps, N. .............................................. 23
Arrar, M. ....................................................................... 48
Arver, S. ........................................................................ 38
Ashby, J. ....................................................................... 34
Assalian, P. ............................................................. 23, 48
Athanasiadis, L. ...................................................... 29, 39
Athanasopoulos, A. ....................................................... 30
Atlantis, E. .................................................................... 37
Austoni, E. .................................................................... 34
Aversa, A. ......................................................... 38, 49, 51
Aydin, M. ...................................................................... 46
Azim jr., H. A. ............................................................... 41
C
Cabello, F. ..................................................................... 22
Calomfirescu, N. ........................................................... 38
Camera, A. .................................................................... 31
Carufel, F. de ................................................................ 23
Caruso, S. ............................................................... 22, 56
Castela, A. .............................................................. 26, 46
Castiglione, F. .......................................................... 26, 46
Castroviejo Royo, F. ................................................. 55, 56
Cayan, S. ...................................................................... 39
Celant, G. ...................................................................... 35
Cellek, S. .......................................................... 25, 36, 46
Chantada, V. ................................................................. 22
Chen, J. ........................................................................ 39
Chevret-Measson, M. .............................................. 39, 41
Chitale, S. ..................................................................... 32
Choi, Y. S. ..................................................................... 46
Chung, W.-S. ................................................................. 25
Ciocca, G. ..................................................................... 30
Claes, H. ................................................................. 38, 51
Clayton, A. H. .......................................................... 27, 41
Clement, P. ................................................................... 26
Colombo, F. ....................................................... 22, 32, 34
Colson, M. H. ................................................................ 23
Cormio, L. C. ................................................................. 32
Corona, G. .......................... 24, 33, 35, 37, 42, 43, 49, 51
Cortes, E. ...................................................................... 30
Costa, C. ................................................................. 23, 36
Courtois, F. .................................................................... 32
Cruz, N. ...................................................... 22, 37, 42, 43
Cudicio, P. .................................................................... 23
Cuzin, B. ..................................................... 23, 39, 43, 44
Cybulska, B. ................................................................. 39
B
Bae, W. J. ..................................................................... 46
Bandini, E. .................................................................... 54
Bannowsky, A. .............................................................. 52
Barsotti Santos, D. ........................................................ 56
Basaria, S. .................................................................... 26
Basar, M. ...................................................................... 37
Becerra, A. ............................................................. 50, 54
Becher, E. ..................................................................... 30
Belgrano, E. .................................................................. 27
Belkoff, L. ..................................................................... 35
Bernorio, R. .................................................................. 22
Bettocchi, C. ........................................................... 33, 34
Bianchessi, I. ................................................................ 47
Biglia, N. ....................................................................... 41
Bitzer, J. ..................................................... 29, 33, 39, 45
Bizic, M. ....................................................................... 38
Blachère, P. .................................................................. 23
Boddi, V. ....................................................................... 38
Bolmont, M. .................................................................. 48
Bondil, P. .................................................... 29, 48, 53, 56
Bonierbale, M. ........................................................ 23, 24
Borg, C. ........................................................................ 32
Both, S. .................................................................. 23, 28
Bou Jaoudé, G. ............................................................. 23
Brigati, A. ...................................................................... 43
Brodak, M. .................................................................... 53
D
Damsted Petersen, C. ................................................... 39
Darabi Mahboub, M. R. ................................................. 57
Dean, J. ............................................................ 26, 41, 42
Debruyne, F. ........................................................... 25, 37
Dehò, F. ........................................................................ 22
Del Río Olvera, F. J. ....................................................... 29
Dente, D. ...................................................................... 38
Dimitropoulos, K. .......................................................... 31
Djinovic, R. ....................................................... 24, 27, 34
Djordjevic, M. ................................................................ 31
Doumas, M. .................................... 27, 38, 41, 48, 49, 55
Dugrè, H. ...................................................................... 23
61
E
H
Eardley, I. ................................................................ 24, 25
Eid, J. F. ........................................................................ 32
Eros, E. ......................................................................... 48
Hackett, G. ................................................. 24, 34, 50, 51
Hakobyan, S. ................................................................ 29
Ham, B. K. .................................................................... 53
Hartmann, U. ................................................................ 35
Hattat, E. ...................................................................... 41
Hattat, H. .......................................................... 30, 31, 52
Hattat, I. ....................................................................... 41
Hatzichristodoulou, G. ................................................... 38
Hatzichristou, D. ........................................................... 39
Hatzimouratidis, K. .................................................. 25, 35
Hedlund, P. ................................................................... 25
Hellstrom, W. ................................................................ 31
Ho, C. C. K. ............................................................. 38, 52
Horizonte, B. ................................................................. 23
Hoscan, M. B. ............................................................... 56
Hotta, Y. ........................................................................ 46
Hughes, B. ............................................................. 47, 56
Hulth, M. ...................................................................... 57
Hyun, J. S. .................................................................... 46
F
Fabre, L. F. ............................................................. 24, 47
Fabrizi, A. ..................................................................... 22
Faix, A. ................................................................... 23, 34
Fekete, F. ...................................................................... 57
Ferrero, S. ..................................................................... 29
Fisher, A. D. .................................................................. 49
Fode, M. ....................................................................... 57
Foldès, P. ................................................................ 23, 24
Foresta, C. .............................................................. 29, 39
Fotas, A. ................................................................. 52, 53
Franceschelli, A. ........................................................... 53
Fusco, F. ....................................................................... 43
G
Gadalla, K. .............................................................. 51, 52
Gadda, F. ...................................................................... 53
Galiano, M. ................................................................... 23
Gallo, L. .................................................................. 51, 54
Garaffa, G. .............................................................. 33, 34
Garattini, L. ................................................................... 29
García-Cruz, E. ........................................................ 22, 50
Gardella, B. ................................................................... 56
Gateva, A. ..................................................................... 32
Gavriilaki, E. ............................................................ 48, 55
Gentile, V. ..................................................................... 33
Gentilini, O. ................................................................... 41
Georgiadis, J. ................................................................ 23
Georgieva, R. ................................................................ 55
Gianotten, W. L. ...................................................... 37, 42
Gilbert, S. M. ................................................................. 37
Giraldi, A. .............................................. 33, 36, 39, 41, 44
Giuliano, F. .................................................................... 30
Goldmeier, D. .................................................... 29, 34, 36
Goldstein, J. .................................................................. 47
Goldstone, S. ................................................................ 29
Gontero, P. .................................................................... 37
Gorin, A. ....................................................................... 24
Gorpynchenko, I. ........................................ 31, 52, 54, 56
Gravina, G. L. ................................................................ 56
Graziottin, A. ............................................... 22, 33, 38, 45
Gruenwald, I. .................................................... 30, 35, 42
Gulino, G. ..................................................................... 31
Gülpinar, Ö. .................................................................. 48
Gutiérrez, P. .................................................................. 22
I
Incrocci, L. .................................................................... 37
Ioakeimidis, N. .................................................. 24, 35, 46
Isidori, A. .......................................................... 26, 33, 43
Issad, M. ....................................................................... 23
J
Jang, S.-Y. .................................................................... 54
Jannini, E. ......................................................... 25, 39, 42
Javier del Río, F. ............................................................ 22
Jawhari, D. .................................................................... 23
Jern, P. ................................................................... 36, 42
Johnson, M. D. ............................................................. 57
Jones, B. C. .................................................................. 39
Joshi, U. ....................................................................... 57
K
Kadihasanoglu, M. ........................................................ 24
Kadioglu, A. ............................................................ 24, 27
Kalejaiye, O. .................................................................. 51
Kamnerdsiri, W. ............................................................ 47
Kataoka, T. .................................................................... 25
Kell, P. .......................................................................... 36
Kendirci, M. .................................................................. 35
Kim, J. .......................................................................... 51
Kim, J. Y. .......................................................... 31, 53, 57
Kim, S. J. ...................................................................... 28
62
Michetti, P. M. ............................................................... 36
Mikkelsen, A. H. ........................................................... 47
Minhas, S. .................................................. 24, 31, 34, 43
Min, K.-S. ..................................................................... 36
Mitroi, G. ................................................................. 52, 53
Moncada, I. ...................................................... 22, 27, 31
Mondaini, N. ........................................................... 36, 39
Montorsi, F. ....................................................... 30, 37, 53
Montorsi, P. ............................................................. 27, 34
Moon, D. G. .................................................................. 50
Moon, K. H. .................................................................. 54
Morales, A. M. .............................................................. 37
Morelli, A. ..................................................................... 28
Morgentaler, A. ....................................................... 26, 33
Morgia, G. ..................................................................... 33
Morrison, B. ............................................................ 51, 53
Mulhall, J. P. ................................................................. 37
Müller, R. ...................................................................... 54
Muneer, A. .................................................................... 39
Mutinelli, P. ................................................................... 55
Kirana, P.-S. ................................................ 32, 42, 44, 45
Kojanova, M. ................................................................. 56
Kojovic, V. ..................................................................... 38
Kotseva, K. .................................................................... 37
Kottmel, A. .................................................................... 32
Koukos, S. .................................................................... 49
Kowalczyk-Amico, K. ..................................................... 56
Kropman, R. ........................................................... 43, 44
Kulchavenya, E. ............................................................ 36
L
Læssøe, N. .................................................................... 32
Laursen, B. S. ......................................................... 47, 56
Lee, H.-S. ..................................................................... 46
Lee, J. H. ................................................................ 46, 47
Lee, S. W. ............................................................... 36, 54
Lee, W. K. ............................................................... 48, 54
Leonardi, R. .................................................................. 32
Lew-Starowicz, M. ......................................................... 47
Liguori, G. ..................................................................... 22
Limoncin, E. ............................................................ 36, 48
Lin, D. .......................................................................... 57
Lindeborg, L. ................................................................. 31
Lonnee-Hoffmann, R. A. ............................................... 55
Lopes, T. ....................................................................... 31
Lotti, F. .......................................................................... 28
Lowenstein, L. ......................................................... 30, 45
N
Nakopoulou, E. ............................................................. 57
Nale, D. ........................................................................ 31
Nappi, R. E. .................................... 25, 27, 30, 33, 39, 44
Naskhletashvili, V. ......................................................... 52
Neves, D. ...................................................................... 28
Nieschlag, E. ................................................................. 33
Nim, C. ................................................................... 24, 33
M
Maggi, M. ............................................................... 33, 34
Mahgoub, M. ................................................................ 55
Maio, G. .................................................................. 50, 51
Maksym, R. .................................................................. 52
Manea, C. N. ................................................................ 49
Markos, A. .............................................................. 47, 50
Marston, C. ................................................................... 39
Martinez-Salamanca, J. I. .................................. 23, 27, 43
Martini, E. ..................................................................... 55
Martín-Morales, A. .................................................. 24, 51
Marzotto Caotorta, M. .................................................... 24
Mashal, A. .................................................................... 51
Mas, M. .................................................................. 22, 34
Mattern, A. .................................................................... 35
McCarthy, B. ................................................................. 39
McCormack, S. ............................................................. 36
McMahon, C. ................................................................ 35
Mears, A. ...................................................................... 34
Meijide, F. ..................................................................... 22
Mianiti, M. .................................................................... 22
O
Özer, Z. ......................................................................... 49
Ozkara, H. .................................................................... 52
Ozorak, A. ..................................................................... 49
P
Pacheco-Figueiredo, L. ................................................. 48
Paduch, D. ............................................................. 28, 54
Palacios, S. ............................................................. 27, 41
Palefsky, J. M. ............................................................... 29
Palmas, A. .................................................................... 53
Palmieri, A. ................................................................... 22
Palminteri, E. .................................................... 27, 43, 53
Palumbo, F. ............................................................ 22, 43
Papaharitou, S. ............................................................. 29
Park, H. J. .............................................................. 48, 51
Park, J. K. ..................................................................... 52
Park, K. ........................................................................ 51
Passavanti, G. ............................................................... 52
63
Souillac, I. ..................................................................... 53
Spera, E. ....................................................................... 22
Sramkova, T. ................................................................. 47
Stoian, D. ................................................................ 31, 32
Suh, J.-K. ...................................................................... 25
Szubert, M. ................................................................... 56
Pastore, A. L. ................................................................ 28
Perdzynski, W. .............................................................. 32
Peretianu, D. ................................................................. 50
Pescatori, E. .................................................................. 52
Petersen, C. D. ...................................... 32, 33, 42, 44, 45
Porst, H. ........................................................... 25, 30, 43
Prieto, R. ...................................................................... 22
T
Tajkarimi, K. .................................................................. 52
Tarabrina, N. ................................................................. 56
Teixeira, A. .................................................................... 57
Tomada, I. .............................................................. 25, 28
Torres, L. O. .................................................................. 23
Triantafyllou, A. ....................................................... 49, 55
Triantafyllou, G. ....................................................... 49, 55
Trombetta, C. ................................................................ 28
Tunckiran, A. ................................................................ 56
Q
Quattrini, F. ................................................................... 57
R
Raheem, A. ............................................................. 35, 57
Ralph, D. .................................................... 24, 32, 33, 34
Rastrelli, G. ....................................................... 25, 28, 50
Reisman, C. ............................................................ 43, 44
Ricca, V. ....................................................................... 27
Rodriguez Tolra, J. ........................................................ 50
Rojas-Cruz, C. ............................................................... 31
Rokkas, K. ............................................ 27, 35, 38, 47, 49
Rosen, R. C. ........................................................... 27, 37
Rossi, R. ....................................................................... 22
Rubio-Aurioles, E. ......................................................... 38
U
Ückert, S. ............................................................... 26, 28
Ur Rehman, K. .............................................................. 50
Usta, M. F. .............................................................. 34, 43
V
Vaccari, R. .................................................................... 53
van Eyle, J. ................................................................... 38
Vansintejan, J. .............................................................. 35
Vardi, Y. ........................................................................ 43
Veale, D. ....................................................................... 27
Vendeira, P. ............................................................ 22, 37
Vercellini, P. .................................................................. 29
Vignozzi, L. ....................................................... 25, 28, 42
Virag, R. .................................................................. 25, 49
Vita, A. .......................................................................... 39
Vlachopoulos, C. ......................................... 24, 27, 34, 50
S
Saad, F. .................................................................. 24, 50
Sacca, A. ...................................................................... 29
Salonia, A. .............................................................. 52, 57
Salvatore, S. .................................................................. 29
Sampaio, F. ............................................................. 46, 47
Sansalone, S. ................................................................ 24
Santisteban, M. ............................................................. 22
Sarquella, J. .................................................................. 22
Sasso, F. ....................................................................... 28
Schindler, A. E. ............................................................. 29
Schneider, T. ................................................................. 52
Schultheiss, D. ........................................................ 35, 37
Sedigh, O. R. ................................................................ 24
Seftel, A. ................................................................. 25, 35
Segura, A. ..................................................................... 22
Semenza, J. .................................................................. 36
Shabbir, M. ................................................................... 27
Shaeer, O. ............................................................... 48, 57
Shamsodini, A. ........................................................ 24, 34
Shechter, A. .................................................................. 35
Shin, H. S. .................................................................... 50
Shiota, A. ...................................................................... 26
Silani, V. ........................................................................ 27
Simonelli, C. ................................................ 22, 27, 39, 42
Sironi, G. E. ................................................................... 30
Skrzypulec-Plinta, V. ............................................... 30, 49
Song, S. H. ............................................................. 50, 54
Son, H. ................................................................... 50, 54
Sønksen, J. ....................................................... 27, 35, 57
W
Waldinger, M. D. ............................................... 30, 42, 45
Wang, R. ....................................................................... 47
Weiss, P. ....................................................................... 29
Wierckx, K. ................................................................... 54
Wu, F. .......................................................................... 33
Wylie, K. ........................................................... 39, 42, 44
Wyllie, M. G. ................................................................. 30
Y
Yaman, O. ..................................................................... 33
Yoon, B. I. ..................................................................... 46
Yun, T. K. ................................................................ 31, 38
Z
Zacharakis, E. ................................................... 32, 37, 53
Ziaei, T. ................................................................... 47, 55
Zitzmann, M. ................................................................ 33
Zucchi, A. ..................................................................... 30
64
Sa
e
h
t
ve
!
e
t
da
EUROPEAN SOCIETY
FOR SEXUAL MEDICINE
15th CONGRESS OF THE EUROPEAN
SOCIETY FOR SEXUAL MEDICINE
6 – 9 December 2012 > RAI Amsterdam Convention Centre, The Netherlands
www.essm.org
Hosted by: the dutch Society for Sexual Medicine
Wetenschappelijke Vereniging voor Seksuele disfuncties, WVSd
Notes
66
Eli Lilly and Company Satellite Symposium
WHY WHAT WHEN:
FACETS OF HUMAN SEXUALITY—
FROM EVOLUTIONARY TO TREATMENT SUCCESS
FRIDAY, 2 DECEMBER, 2011: 12.30-13.30
MILANO CONVENTION CENTRE: RED ROOM
MILAN, ITALY
Commonly, sexual motivation is perceived as a
general drive, with individual behaviours being
culturally shaped and modified.
12.30
WELCOME
Ian Eardley
Chairperson
United Kingdom
12.35
WHY DO WE HAVE SEX?
BIOLOGICAL EVOLUTION
OF HUMAN SEXUALITY
Dietrich Klusmann
Germany
12.50
WHAT ARE THE MYTHS AND FACTS
OF OUR SEXUAL BEHAVIOUR?
Annamaria Giraldi
Denmark
13.05
WHEN SEXUAL LIFE IS IN TROUBLE—
WHY “BACK TO NORMAL?”
Ian Eardley
United Kingdom
13.25
WRAP-UP
Ian Eardley
United Kingdom
13.30
PROGRAMME ADJOURNMENT
Is it really that simple?
Why is it important to closely look into evolutionary
as well as emotional programmes to better
understand human sexuality?
What is the evidence mirroring current
sexual habits?
When sexual life is impaired, treatment options
should focus on restoring quality of life for
concerned patients and partners. How can this
treatment goal be reached?
This Lilly Satellite Symposium will deal with facets
of human sexuality and provide answers to these
questions.
On behalf of the distinguished faculty and the Lilly
European Medical Urology Team, we very much
look forward to welcoming you in Milan.
www.essm.org

14th CONGRESS OF THE EUROPEAN SOCIETY

Transcription

Similar documents

Media : Metro Ahad Section : Setempat Date

L`ombelico del mondo

SEXtend \seks tend \ - Student Health Center

Intimissimi has a great history behind it. The extraordinary

The World Game. How t - The World Game Italy

www.fsnb.org.uk - Fresh Start New Beginnings

Both WAVAW and SAS will support whatever decisions you make.

questionnaire for patients

wINekITz.com - Winekitzkamloops.com

WRITE Brochure